.
December, 2014
CURRICULUM VITAE
Zeev Blumenfeld, MD
(ID # 6508441)
Date & Place of Birth: 20th October 1949, Iasi, Romania
Date of Immigration: January 1959, with parents and brother
Family Status: Married 1972, wife Ruth
Private address: 14 Vitkin St, Haifa, 34756.
Work address: Reproductive Endocrinology, Dept. OB/GYN, Rambam Health Care Campus, Rappaport Institute,
Technion-Faculty of Medicine, Haifa, 31096, Tel: 972-4-8542577 ; Fax: 972-4-8543243
, z_blumenfeld@rambam.health.gov.ilbzeev@techunix.technion.ac.il
ACADEMIC DEGREE
1976- MD - Hebrew University and Hadassah Medical School, Jerusalem.
ACADEMIC APPOINTMENTS
1994- Associate Professor of Obstetrics & Gynecology, Faculty of Medicine, Technion.
1990-1994 Senior Lecturer, Technion
1969-1973 Research and teaching assistant at the Department of Anatomy and Embryology; Hebrew University
and Hadassah Medical School (Teaching anatomy, embryology, and neuroanatomy).
1973-1974 Associate teaching fellow in the Department of Anatomy and Morphologic Sciences, Technion.
PROFESSIONAL EXPERIENCE
2010- Director, Reproductive Endocrinology, RAMBAM Health Care Campus.
1997-present- Director–“Woman’s Health Center”, in charge of Ob.Gyn. Service, Haifa and Northern Israel of
“Meuhedet health care services”.
1985 Senior Physician. Reproductive Endocrinology and Infertility, OB/GYN, Rambam Med. Ctr. Haifa,
1983-85
Fellowship in Reproductive Endocrinology, with Prof. RB Jaffe, Univ. California, San-Francisco.
1977-1983 Residency in Obstetrics and Gynecology at Rambam Medical Center, Haifa,
1978-1981 Post graduate course/Obstetrics & Gynecology.Sackler School of Medicine, Tel Aviv University.
1976-1977 Commander of medical officers courses/ Military Medical School. Last military rank - Major.
1974-1977 Compulsory service in Israel Defense Forces as military physician.
1973-1974 Internship at Rambam Medical Center, Haifa, Israel.
RESEARCH INTERESTS
Research Gate score 43.22. 12,000 publication views.
Prevention of premature ovarian failure (POF) in young women receiving gonadotoxic chemotherapy.
Reproductive Endocrinology
Inhibin & Activin in Human Reproduction
Hypophysiotropic and Neuregulatory Modulation of Fetal Human Pituitary.
Infertility and Assisted Reproduction (ART)
Immunologic Problems in Infertility
TEACHING EXPERIENCE




2009-2011 - Chairman of Ob.Gyn. teaching curriculum, Rappaport Faculty of Medicine, Technion.
1985-present Teaching Ob.Gyn. & Reproductive Endocrinology and Infertility to medical students.
1987-1995 Co-director- elective course "Physiology of Reproduction", medical & graduate students.
1995-8 Co-director of Post Graduate Course in Ob.Gyn. Rappaport Faculty of Medicine, Technion.
 1995-present - Director of Post Graduate/Elective Course: "Reproductive Endocrinology" #277215 to
postgraduate students, Technion, Faculty of Medicine..
 2005- Academic Director- Postgraduate course- OB/GYN to certified Obstetricians & Gynecologists/
Technion – Unit of Postgraduate education.
 2002-8 Director of “Physiology of Reproduction” course, Haifa University, Faculty of health science.
 2008-13 Director of Endocrinology Course # 274229, Technion American Students Program.
 2008-9 Director of Endocrinology Course #274338, medical & graduate students. Faculty of Medicine.
1
.
TECHNION ACTIVITIES
1995-8 Member of the research committee; Rappaport Faculty of Medicine.
1997- Chairman of the Sub-Committee for grants: Technion - Ministry of Health – Hospitals.
1992-4; 2006-present- Member of teaching committee; chairman of the Ob/Gyn curriculum, Rappaport Faculty
of Medicine, Technion.
2008-13 Director of Endocrinology Course # 274229, Technion American Students Program.
2008-9 Director of Endocrinology Course # 274338 to medical students, Faculty of Medicine.
2009-present, Chairman of Ob.Gyn. Curriculum, Rappaport Faculty of Medicine, Technion.
PUBLIC PROFESSIONAL ACTIVITIES
2008-present Editor in Chief- "Clinical Medicine Insight: Reproductive Health".
2013- "
Editor in Chief- "Journal of Reproductive Biology and Health".
2005- " Editorial board member- European J. Obstetrics, Gynecology & Reproductive Biology
2013-16
Editorial board member: JCEM- Journal of Clinical Endocrinology & Metabolism.
2011-present Editorial board member: Fertility and Sterility.
2014Editorial board member: Expert Review of Endocrinology & Metabolism.
2007Editorial board member: Recent Patents Endocrinol, Metabol & Immune Drug Discovery.
2007Editorial board member: "Open Tissue Engineering & Regenerative Medicine."
2007Editorial board member: "The Open Reproductive Science Journal."
2008Editorial board member: "Stem Cells and Cloning: Advances & Applications."
2008Editorial board member: "Transplantation Journal."
2009Editorial board member: "Stem Cells Review Letters (SCRL)"
2009Editorial board member: "IVF News Direct"
2010Editorial board member: "J of Adolescent and Young Adult Oncology’"
2011-14
Editorial board member: "Chinese Journal of Clinicians"
2011Editorial board member: "World Journal of Translational Medicine"
2011Editorial board member: "The Scientific World Journal-Endocrinology Domain".
2011Editorial board member: "International Journal of Biological Engineering".
2011-15
Editorial board member: World Journal of Obstetrics and Gynecology.
2013Editorial board member - Gynecology.
2013Editorial board member - International Journal of Pediatrics and Child Health.
2013Founding Editorial board member - Am J Clin Exp Obstet Gynecol.
2013Editorial board member - Frontiers in Biological Chemistry(FBC)
1991-1994 Reviewer (Referee) Ad Hoc of the J. of Clinical Ultrasound.
1992-present Reviewer (Referee) Ad Hoc of Fertility & Sterility.
1993Reviewer (Referee) Ad Hoc of Obstetrics and Gynecology.
1992-2009Reviewer-grants submitted to the Chief Scientist - Israel Ministry of Health.
1993Referee of the US-Israel BARD Fund.
1994-98 Reviewer (Referee) Ad Hoc of Ultrasound in Obstetrics and Gynecology.
1995-14 Reviewer of abstracts - annual meetings of the Society of Gynecologic Investigation (SGI).
1995- Reviewer Ad Hoc of the Israel Journal of Obstetrics and Gynecology.
1996- Reviewer (Referee) of the Israeli National Fund of Science (Academy).
1997- Reviewer (Referee) Ad Hoc of the European Journal of Endocrinology.
1997- Scientific Prize Committee - Israel Endocrine Society.
1998- Scientific Prize Committee - Israeli Fertility Association.
1998- Reviewer of the Journal of Assisted Reproduction & Genetics.
1998- Reviewer (Referee) Ad Hoc of "Harefuah".
1998/9 Reviewer of the Israel Endocrine Society annual meeting.
1999 Reviewer of Journal Club in Reproductive Medicine and Ferti Net.
1999-2000Member of European Community jury -grants evaluation and funding, Brussels, Belgium.
2000- Review Ad Hoc of Israel Medical Association Journal .
2
.
2000-9 Reviewer of grants - Israeli Ministry of Health/ member of the evaluation committee.
2001Advisor to “Fertile Hope” organization
2001-10 Reviewer ad hoc of Bio Medical Women’s health journal.
2001Reviewer-Human Reproduction.
2002
Reviewer-Pediatric Research journal
2002
Reviewer-Cancer Control
2002
Reviewer- Asian Jurnal of Andrology
2002
Reviewer- American J. of cancer.
2003
Reviewer- Arthritis Research Campaign Clinical Research Fellowship
2003
Reviewer- Clinical Lymphoma journal.
2003
Reviewer- Drug Safety journal
2003
Reviewer- Fetal Diagnosis and Therapy
2004
Invited Guest Editor of “Fertility drugs, in vitro fertilization and the risk of gynaecological
malignancies” published in the CME Journal of Gynecologic Oncology.
2004- Reviewer- Leukemia.
2004- Reviewer- The Journal of Clinical Endocrinology & Metabolism.
2004- Reviewer- Hematologica.
2004- Reviewer –European J of Clinical Nutrition, Nature Publishing Group
2004 Reviewer - Cancer for Physicians
2004- Reviewer-consultant for “BASHAAR”educational academic program.
2004 Organizing committee: Meuhedeth Medical Services Congress– 2004, 2008,2012.
2005 Reviewer- Future Medicine- Women’s Health
2005- Reviewer- Gynecologic and Obstetric Investigation.
2005- Reviewer- Clinica Chimica Acta
2005- Organizing committee: “Oncology Overall “Meuhedet Medical Services,10.2005.
2005- International project of experts on the etiology and treatment of Uterine Fibroids
2005- Reviewer- Women Health Journal.
2005- Project expert evaluator for the Piedmont Region of Italy for industrial research calls.
2006- Reviewer- Expert Review of Obstetrics & Gynecology
2006- Reviewer- The Medical Journal of Australia.
2006-7 Reviewer- Journal of Endocrinological Investigation.
2006- Reviewer- GIF – German Israeli Foundation
2006- Reviewer- Reproductive Sciences.
2007- Reviewer - Expert Review of Obstetrics & Gynecology.
2007- Reviewer - Expert Review of Nature Clinical Practice Rheumatology.
2007- Reviewer – Medical Science Monitor.
2007- Reviewer – Human Reproduction Update.
2007- Reviewer - Expert Review of Anticancer Therapy
2008- Reviewer – Gender Medicine.
2008- Reviewer – PLACENTA.
2008- Reviewer – Cancer Research UK
2008- Reviewer – The Oncologist.
2008- Reviewer – Reproductive Bio Medicine –RBM online.
2008- Reviewer – Expert Review of Endocrinology and Metabolism.
2008- Reviewer – Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.
2008- Reviewer – NPG-British J. cancer
2008- Reviewer-- International Journal of Biomedical Science (IJBS).
2009- Reviewer – Cancer.
2009- Reviewer – Regulatory Peptides.
2009- Reviewer – Scandinavian Journal of Rheumatology.
2009- Reviewer – British Journal of Haematology.
2009- Reviewer – Journal of Women's Health
2009- Reviewer – International Journal of Diabetes in Developing Countries.
3
.
2009- Reviewer – Journal of Endocrinological Investigation.
2010- Reviewer- Biomed Central [BMC] - Cancer.
2010- Reviewer- American J. Obstet. Gynecol.
2010- Reviewer- Diabetes in Developing Countries.
2010- Reviewer - Expert Reviews in Pharmacotherapy. [Invited Editorial].
2010- Reviewer - Expert Opinion on Emerging Drugs
2010- Reviewer - Cellular Oncology
2010- Reviewer –Archives of Gynecology and Obstetrics.
2011-14Advisor to minister of defense veterans committee.
2011- Reviewer- The Lancet Oncology.
2011- Reviewer- The Cochrane Gynecological Cancer and Orphan Cancer Review.
2011- Reviewer- The J of Reproductive Medicine.
2011- Reviewer- The Open Reproductive Science Journal.DUCTIVE SCIENCE JOU
2011- Reviewer- Medical Science Monitor.
2012- Reviewer- PLOS One.
2012- Reviewer- J. Fertilization in Vitro, OMICS publishing group.
2012- Reviewer- SCIENCE Translational Medicine
2013- Reviewer- European Oncology & Haematology.
2013- Reviewer- Nature Reviews Endocrinology.
2013Reviewer- British Journal of Hematology. Journal of Cancer Research and Clinical
Oncology
2013- Reviewer- Advances in Therapy.
2013-15Reviewer- Current Medical Research & Opinion.
2013- Reviewer- Leukemia and Lymphoma.
2013- Reviewer- Journal of Chemotherapy.
2013- Reviewer- Reproductive BioMedicine Online.
2013- Reviewer- DNA and Cell Biology.
2013- Reviewer- Applied Scientific Reports.
2013- Reviewer- Cancer Treatment Reviews
2013- Reviewer- British Journal of Hematology.
2013- Reviewer- The Lancet
2014- Reviewer- J. Cancer Research and Clinical Oncology.
2014- Reviewer- Hum Reproduction Update
2014- Reviewer- Current Medical Research and Opinion
2014- Reviewer- Circulation
2014- Reviewer of grants for GIF- Germany Israel Foundation.
2015- Reviewer- Journal of Nutrition and Health.
MEMBERSHIP IN PROFESSIONAL SOCIETIES
International
Society for Gynecologic Investigation (Membership # 462-114).1987-present.
The Endocrine Society, (Membership # 138759) Membership. 1987-present.
Israel National representative to ESHRE [European Society of Human Reproduction & Embryology] 2012- present.
New York Academy of Sciences (Membership # 336939). 1990-2013.
American Society for Reproductive Medicine (former- American Fertility Society).1983-present
European Society of Human Reproduction and Embryology.2010-present
Member of the executive committee of ESHRE [European Society of Human Reproduction & Embryology]
task force of "Fertility Preservation in Severe Diseases". 2007-11
Reproductive Biology Professional Group.
International Society of Gynecological Endocrinology. 1989-present
4
.
Member of Research Board of Advisors (ABI). 2000-present
Member of Board of Advisors (Fertile Hope). 2000-present.
Member of International Society of Fertility Preservation.2008-presenr
Member of COPE- Committee on Publication Ethics. 2012-present
National
Israeli Endocrine Society. Member of the executive council (2008-2012 ).
Israeli Society for Fertility Research [AYALA-- ‫ [איל''ה‬member of directory council (1991-1995).
HONORS
1970-1973-Maurberger prize [for four years]-excellence in medical studies, Hebrew University, Jerusalem.
1988- Received the Polishuk award for the research: "Luteal Dysfunction in Ovulation Induction - The Role of
Repetitive Human Chorionic Gonadotropin Supplementation during the Luteal Phase" - The annual meeting of
the Israeli Society for Reproduction Research.
1991-The Zondek Prize for the best abstract 1990-91, the annual meeting of the Israeli Endocrine Society (IES),
1991: "Growth hormone-binding protein (GH-BP) correlation with estrogen, progesterone, and gonadotropins
in human: The effect of ovulation induction with growth hormone, hMG, and gestation".
1991- Elected as member of the "Society for Gynecologic Investigation".
1992- Prize of the Israel Fertility Society for the research "Growth Hormone - Binding Protein regulation in
preovulatory follicles: Correlation with serum GH-BP levels".
1992- Member-Board Examinations, Obstetrics & Gynecology, Israeli Scientific Council.
1999-2000
Member of European Community Jury-grants evaluation, Brussels, Belgium.
2007-2010 Member of the ESHRE task force "Fertility Preservation in Severe Disease"
2007- Nomination as "Outstanding reviewer" of Fertility and Sterility.
2008- Editor in Chief- ‘Clinical Medicine Insight: Reproductive Health’.
2013- Editor in Chief- "Journal of Reproductive Biology and Health".
2010-The best clinical poster Prize, the 39th annual meeting of the Israeli Endocrine Society (IES):"The
protective effect of GnRH-a against chemotherapy associated gonadal failure in stem cell transplantation".
2011- Prize poster, the annual meeting of the Society for Gynecologic investigation (SGI), Miami beach,
Florida, US: "The protective effect of GnRH-a against chemotherapy associated gonadal failure in stem cell
transplantation".
2011- present- National representative in ESHRE.
GRADUATE STUDENTS
Graduate Students
1.
2.
3.
4.
5.
6.
Alona Doubleman (M.Sc.) - 1999
Karina Tareschenkov (M.Sc.) – 2004 – Co-instruction with Dr. Michal Lahav, D.Sc.
Lana Kuperschmidt-Nasachev, (M.Sc. - 2007).
Hadas Cohen, (M.Sc. - 2010).
Orly Turgeman, (M.Sc. - 2011).
Dr. Marina Ritter, MD (for D.Sc.) –stopped due to chronic illness.
Basic Science
7. Dr. Nina Boulman, MD 2004, Basic science - completion of residency in Internal Medicine.
8. Dr. Onith Sella-Guttman, M.D.2004-5, Basic science for completion of residency in Ob.Gyn.
MD Thesis
9. Dr. J. Ulman - 1983
10. Dr. S. Jacobson-Sadetsky - Prize for best faculty MD thesis - 1987
11. Dr. S. Hanania - 1988
12. Dr. B. Zilberman - 1988
5
.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
Dr. M. Dudkevitz - 1990
Dr. Ron Shiloh - 1994
Dr. I. Matza-Avivi - 1994 (Cum Laude) - Prize for best faculty MD thesis.
Dr. I. Chai - 1994 (Cum Laude).
Dr. A. Schwartz - 1995.
Dr. A. Raz - 1996.
Dr. I. Pery - 1997 - Prize for outstanding faculty MD thesis.
Dr. S. Shoval - 1997.
Dr. D. Toib Bejerano-1998 (Cum Laude). Prize for outstanding faculty MD thesis.
Dr. D. Laniado - 1998. - Prize of outstanding faculty MD thesis.
Dr. A. Yaron - 1998. - Prize of outstanding faculty MD thesis.
Dr. L. Reubenoff-Pas - 1999
Dr. R. Seligson – 1999
Dr. Amit Damty- 2006
Dr. Biren Patel- 2010- Prize of outstanding poster [IES 2010 and SGI 2011].
Hilly Zur – 2014
Olivia Diamond – 2014
Emily Herzberg – 2014 – Prize for outstanding faculty MD thesis.
RESEARCH GRANTS
1. "Hypophysiotropic and Neuroregulatory Modulation of Human Fetal Pituitary Cells to Inhibin,
Activin and other Hypothalamic Releasing Factors", Technion- Israel Institute of Technology,
$1,000.-, 1990. Bi-National US-Israel Scientific Fund (BSF) 1994-1997 - $35,000/year (3 years).
2. "On and Off Treatment of Uterine Leiomyomata with a GnRH Agonistic Analog (Nafarelin)", Syntex,
USA, $15,000. 1989-90.
3. "Effect of Desogestrel Versus Levonorgestrel Containing Birth Control Pills on Lipoprotein Profile".
Organon, USA, $12,000.1989-90.
4. "Cotreatment of Growth Hormone & hMG in Clonidine Negative Patients", Israel Fertility Society,
NIS 1,000. 1990.
5. "Regulation of Growth Hormone Binding Protein by Sex Hormones and its Role in Reproductive
Endocrinology", Chief Scientist, Ministry of Health, NIS 10,000.- 1992.
6. "Recombinant Human FSH (Gonal-F) in Male Infertility Treatment - an International Multicenter
Study", Serono International, $40,000.- 1992-1993.
7. "Isolation of FSH gene from patients with premature ovarian failure", Chief Scientist, Ministry of
Health, NIS 15,000.- 1993.
8. "Development of a "when-meter" for detection of ovulation".George Amber Fund, $15,000. 1995-97.
9. "Regulation of Human Adrenal Cell Steroidogenesis (in vitro) by androgens" Technion, $500, 1997
10. "In Vitro embryotoxicity of human sera from habitual aborters on rat fetuses". Binational USA Israel
Scientific Fund (BSF) 1997-1999. $38,000/year (3 years) in collaboration with A. Ornoy, Hebrew
University - Hadassah Medical School, Jerusalem.
11. "Preservation of Ovarian Function along chemotherapy in women". Grant from Technion, Ministry of
Health, and Rambam Medical Center. $5,000, 1998.
12. BSF Fund: “Antiphospholipid Antibodies as a Cause for Recurrent Abortions in Women with APS” –
39,000$/year (×3 years) in collaboration with A. Ornoy, Hebrew University - Hadassah Medical
School, Jerusalem, and Prof. Richard Miller, Rochester, NY, USA 2001-2003.
13. "Prevention of Gonadotoxicity by GnRH - Agonists ". MANLAM- Research Fund # 2004220; 2000$.
Submitted to the Israel Science Foundation.In preparation of a multicenter European Integrated Project
for the 7th program of the European Council.
14. Sildenafil for treatment of IUGR and PET – Prize of the Israel Society of Ob.Gyn. 5000 NIS.
15. 2009-11 - Rappaport research institute membership grant- 10,000$/year.
6
.
16. 2010-11 – C. Rosenblatt Cancer research Fund- 5000$. [Fund # 2013771]
ADVANCED STUDIES
1983-1985 Fellowship in Reproductive Endocrinology in the Department of Obstetrics, Gynecology and
Reproductive Sciences, University of California, San Francisco, c/o Robert B. Jaffe, MD.
1993- Exon-Intron Workshop on Molecular Biology - Recombinant DNA Methodology, 1993.
2014- Completed the program of GCP & clinical trials management for PI's.
7
.
LIST OF PUBLICATIONS
Thesis
"Transplacental effect of Thyrocalcitonin and Estradiol Valerate on osteogenesis in rat fetuses", 1973.
REFEREED PAPERS IN PROFESSIONAL JOURNALS
BASIC
1.
Makler A, Blumenfeld Z, Brandes JM, Paldi E: Factors affecting sperm motility. Human sperm
velocity and percentage of motility as influenced by semen dilution. Fertil Steril 1979; 32: 442.
2.
Makler A, Blumenfeld Z: Optimum measurements time for human sperm velocity determination. Arch
Androl 1980; 5:89-194.
3.
Makler A, Blumenfeld Z, David R, Better OS: Factors affecting sperm motility: VII - sperm motility
as affected by change of pH and osmolarity of semen and urine specimens. Fertil Steril 1981; 36:507.
4.
Blumenfeld Z, Kerner H, Thaler I, Deutsch M, Beck D: Increased alpha fetoprotein levels in mixed
mesodermal tumors of ovary. Gynecol and Obstet Invest 1984;17:169-173.
5.
Blumenfeld Z, Makler A, Gershon H, Brandes JM: An improved sperm immobilization test based on
multiple exposure photography technique. Am J Reprod Immunol and Microbiol 1985; 7:27-31.
6.
Blumenfeld Z, Kuhn RW, Jaffe RB: Corticotropin-releasing factor can stimulate gonadotropin
secretion by human fetal pituitaries in superfusion. Am J Obstet Gynecol 1986; 154: 606-12.
7.
Blumenfeld Z, Jaffe RB: Hypophysiotropic and neuroregulatory modulation of ACTH secretion by
human fetal pituitary. J Clin Investig 1986;78: 288-94.
8.
Monroe SE, Blumenfeld Z, Andreyko JL, Schriock E, Henzl MR, Jaffe RB: Dose-Dependent
Inhibition of Pituitary-Ovarian Function during Administration of a GnRH Agonistic Analog
(Nafarelin). J Clin Endocrinol Metabolism 1986; 63:1334-41.
9.
Blumenfeld Z, Gershon H, Makler A, Stoler J, Brandes JM: Detection of antisperm antibodies: A
cytotoxicity immobilization test. Int J Fertil 1986; 31:207-12. 1987 Reviewed and republished in
"International Synopses",.
10.
Mulchahey J, DiBlasio AM, Martin CM, Blumenfeld Z, Jaffe RB: Hormone production and peptide
regulation of the human fetal pituitary gland. Endocrine Reviews 1987;8: 406-22.
11.
Jaffe RB, Mulchahey JJ, DiBlasio AM, Martin C, Blumenfeld Z, Dumesic DA: Peptide regulation of
pituitary and target tissue function and growth in the primate fetus. Proceedings of the Laurenthian
Hormone Conference. Recent Progress in Hormone Research, 1988; 44: 431-59.
12.
Jaffe RB, DiBlasio AM, Blumenfeld Z, Martin MC, Seron-Ferre M: Neuroendocrine regulation of
hormonal function and growth in the primate fetal hypothalamic-pituitary-adrenal system. Perinatal
Press, 1989.
13.
Nahhas F, Blumenfeld Z: The zona-free hamster egg penetration assay: Prognostic indicator in IVF
program. Archives of Andrology 1989; 23:33-7.
14.
Blumenfeld Z, Tapanainen P, Kaplan S, Grumbach M, Jaffe RB: Partial loss of responsiveness of
human fetal pituitary cells to hGHRH after chronic exposure.Acta Endocrinologica1989;121:721-6.
15.
Blumenfeld Z, Weiner Z, Lorber M, Sujov P, Thaler I: Anticardiolipin antibodies in patients with
recurrent pregnancy wastage: Treatment and uterine blood flow. Obstet Gynecol 1991;78: 584-9.
16.
Blumenfeld Z, Amit T, Barkey RJ, Lunenfeld B, Brandes JM: The synergistic effect of growth
hormone and gonadotropins in achievement of conceptions in "clonidine negative" patients with
unexplained infertility. New York Academy of Sciences 1991; 626:250-66.
17.
Makler A, Makler-Shiran E, Stoler J, Lissak A, Abramovici H, Blumenfeld Z: Use of a sealed minichamber to investigate human sperm motility under aerobic and unaerobic conditions. Archives of
Andrology 1992;29:255-61.
18.
Blumenfeld Z, Barkey RJ, Youdim MBH, Brandes JM, Amit T: Growth hormone - binding protein
regulation by estrogen, progesterone, and gonadotropins in human: The effect of ovulation induction
with menopausal gonadotropins, GH and gestation. J Clin Endocrinol Metabol 1992; 75:1242-9.
8
.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
Makler A, Reiss J, Stoler J, Blumenfeld Z, Brandes JM: Use of a sealed mini-chamber for direct
observation and evaluation of the in-vitro effect of cigarette smoke on sperm motility. Fertil Steril
1993; 59:645-51.
Blumenfeld Z, Halachmi S, Pertz B, Shmuel Z, Golan D, Makler A,Brandes JM: Premature ovarian
failure - The prognostic application of autoimmunity on conception after ovulation induction. Fertility
and Sterility 1993; 59:750-5.
Amit T, Dirnfeld M, Barkey RJ, Peleg I, Abramovici H, Hacham H, Blumenfeld Z: Growth hormone binding protein (GH-BP) levels in follicular fluid from human preovulatory follicles: Correlation with
serum GH-BP levels. J Clin Endocrinol Metabol 1993;77:33-9.
Blumenfeld Z, Amit T: The role of GH in ovulation induction.Annals of Medicine1994;9:209-13.
Blumenfeld Z, Dirnfeld M, Gonen Y, Abramovici H, Brandes JM: Growth hormone cotreatment for
ovulation induction may enhance conception in the cotreatment and in the succeeding cycles, in
clonidine negative but not in clonidine positive patients. Human Reproduction 1994; 94:209-13.
Makler A, Yoffe N, Reichler A, Stoler J, Blumenfeld Z: Inability of human sperm to change their
orientation in response to external chemical stimuli. Fertil Steril 1995; 63:1077-82.
Shiran E, Stoller J, Blumenfeld Z, Feigin FD, Makler A: Evaluation of the accuracy of different
counting chambers using strict counts of photographed beads. J Assist. Reprod and Genetics 1995; 12:
434-42.
Blumenfeld Z, Amit T: The role of growth hormone (GH), GH-receptor and GH-binding protein in
reproduction and ovulation induction. Journal of Pediat Endocrinol Metabol 1996; 9:145-62.
Avivi I, Polak S, Gideoni O, Linn S, Blumenfeld Z: Overdiagnosis of 21-hydroxylase late onset
congenital adrenal hyperplasia: Correlation of corticotropin test and human leukocyte antigen typing.
Fertil Steril 1996; 66:557-63.
Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N: Prevention of irreversible
chemotherapy-induced ovarian damange in young women with lymphoma by a gonadotropinreleasing hormone agonist in parallel to chemotherapy. Human Reproduction 1996; 11:1620-6.
Selected and discussed in the Year Book of Hematology, 1998.
Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z: Activated protein C
resistance can be associated with recurrent fetal loss. Br J Haematology 1997; 97:551-4.
Brenner B, Blumenfeld Z: Thrombophilia and fetal loss. Blood reviews 1997; 1:72-79.
Blumenfeld Z, Haim N: Prevention of gonadal damage during cytotoxic therapy. Annals of Medicine
1997; 29:199-206.
Jabareen A. Blumenfeld Z. Younis J, Lanir N, Brenner B: Prevention of recurrent fetal loss and
gestational thromboembolism by enoxaparine. Thromb. Haemostasis 1997 suppl: 783.
Ornoy A, Yacobi S, Avraham S, Blumenfeld Z: The effect of sera from women with systemic lupus
erythematosus and/or antiphospholipid syndrome on rat embryos in culture. Reproductive Toxicology
1998; 12:185-91.
Blumenfeld Z, Ritter M, Shen-Or Z, Shariki K, Ben-Shahar M, Haim N: Inhibin-A concentrations in
the sera of young women during and after chemotherapy for lymphoma: Correlation with ovarian
toxicity. Am. J. Reprod Immunol 1998; 39:33-40.
Krause I, Blumenfeld Z, Malchinsky M, Cohen S, Blank M, Eldor A. Weksler B, Schweitzer K,
Shoenfeld Y: Anti-endothelial cell antibodies in the sera of hyperprolactinemic women. Lupus, 1998;
7:377-82.
Brenner B, Sarig G. Weiner Z, Younis J, Blumenfeld Z., Lanir N: Thrombophilic polymorphisms are
common in women with fetal loss without apparent cause. Throm Haemost 1999; 82:6-9.
Sun QY, Blumenfeld Z, Rubinstein S, Goldman S, Gonen Y, Breitbart H: Mitogen-activated protein
kinase in human eggs. Zygote, 1999; 7:181-5.
9
.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and
minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Invest 1999;
6:229-39.
A,B,C,D- Blumenfeld Z, Brenner B: Thrombophilia associated pregnancy wastage. Fertil Steril 1999;
72:765-774. Selected for: “Continued Medical Education” section of Fertility and Sterility.
A,C,D- Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis J. Enoxaparin improves gestational
outcome in thrombophilic women with recurrent pregnancy loss. Throm Haemost 2000. ; 83:693-7.
A,B,D- Yacobi S, Ornoy A, Blumenfeld Z. Miller RK: The effect of sera from women with systemic
lupus erythematosus (SLE) and recurrent abortions on the proliferation and death of human
trophoblastic cells in culture. Placenta 2000; 21:A37.
A,B,C,D- Blumenfeld Z.: Ovarian rescue/protection from chemotherapeutic agents. J Soc.Gynecol
Invest 2001; 8: S60-64.
A,B,C,D- Blumenfeld Z and Ritter M,: Inhibin, Activin, and Follistatin in Human Fetal Pituitary and
Gonadal Physiology. Ann.N.Y.Acad.Sci. 2001; 943:34-48
A,B,C,D- Blumenfeld Z. Response of human fetal pituitary cells to activin, inhibin, hypophysiotropic
and neuroregulatory factors in vitro. Early Pregnancy, 2001; 5:41-2.
A,D- Sarig G, Younis J, Hoffman R Lanir N, Blumenfeld Z. Brenner B, Thrombophilia is common in
women with pregnancy loss and is associated with late pregnancy wastage. Fertil Steril, 2002; 77: 3427.
A,B,C,D- Blumenfeld Z.: Preservation of fertility and ovarian function and minimalization of
chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin –A and –B
as markers. Molecular Cellular Endocrinology. 2002; 187:93-105.
A,B,C,D- Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe J.M: Fertility after treatment for
Hodgkin’s disease. Annals of Oncology. 2002; 13[Suppl.] 1:138-47.
A,B,D- Yacobi S, Ornoy A, Blumenfeld Z, Miller R. K.: The effect of sera from women with
Systemic Lupus Erythematosus or Antiphospholipid Syndrome and recurrent abortions on human
placental explants in culture. Teratology. 2002; 66: 300-8.
A,B,C,D- Blumenfeld Z. Review- Fertility after chemotherapy. Hungarian J. of Gynecologic
Oncology. 2002; 7:27-40.
A,B- Matalon ST, Shoenfeld Y, Blank M, Yacobi S, Blumenfeld Z, Ornoy A.: The effects of IgG
purified from women with SLE and associated pregnancy loss on rat embryos in culture. Am. J.
Reprod. Immunol.2002; 48: 296-304.
51.
A,B- Ornoy A, Yacobi S, Matalon ST, Blank M, Blumenfeld Z, Miller RK, Shoenfeld Y. The
effects of antiphospholipid antibodies obtained from women with SLE/APS and associated
pregnancy loss on rat embryos and placental explants in culture. Lupus. 2003; 12: 573-8.
52.
A,B,C,D- Blumenfeld Z.: Hormonal suppressive therapy for endometriosis may not improve patient
health. Fertility and Sterility. 2004; 81: 487-92.
53.
A,B,C,D- Boulman N, Levy Y, Leiba R, Schachar S, Linn R, Zinder O, Blumenfeld Z: Increased
C-Reactive Protein levels in the PCOS- a marker of cardiovascular disease. J Clin Endocrinol
Metabol. 2004; 89:2160-65. Endocrine Society-Release to the Press 5.2004. Increased risk of
CVD shown in PCOS patients. Cardiovascular Drug News, May 2004; 49: 26-7.
54.
A,B,C,D- Blumenfeld Z, Eckman A. Preservation of Fertility and Ovarian Function and Minimizing.
Chemotherapy Induced Gonadotoxicity in Young Women by GnRH-A. J.National Cancer Institute
Monogr. 2005; 34:40-3.
55.
A,C,D- Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Blumenfeld Z. The neuroprotective
effect of Activin A and B: implication for neurodegenerative diseases. J Neurochem. 2007; 103:
962-71.
10
.
56.
57.
A,C,D - Rosenberg N, Soudry M, Rosenberg O, Blumenfeld I, Blumenfeld Z. The Role of Activin A in
The Human Osteoblast Cell Cycle: A Preliminary Experimental in Vitro Study. Exp Clin Endocrinol
Diabetes. 2010; 118:708-12.
Evron A, Blumenfeld Z. Ovarian Stem Cells-the Pros and Cons. Clin Med Insights: Reprod Health. 2013;
7: 43-7.
CLINICAL
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
Weisz GM, Blumenfeld Z, Barzilai A: Electrocardiographic changes in traumatized patients. J.
American College of Emergency Physicians and the Univ. Ass. for Emergency Med. Services.
1976; 5:329-31.
Blumenfeld Z, Makler A, Zimmer E, Peer E, Brandes JM: Treatment of hirsutism with Cyproterone
Acetate (Androcur). Harefuah 1980; 99:303.
Blumenfeld Z, Brandes JM, and Timor-Tritsch IE: Pregnancy and extrahepatic portal hypertension.
Harefuah 1980; 98:116.
Dickstein G, Blumenfeld Z, and Barzilai D: The diagnosis and therpeutic approach in Cushing
Syndrome - A critical review. Harefuah 1980; 98:268.
Makler A, Blumenfeld Z, Zimmer E: Evaluating the treatment of the hirsutic women and acne with
cyproterone acetate (Hebrew). Harefuah 1980; 99:303-306.
Kerner N, Blumenfeld Z, Friedman M, Peretz BA, Brandes JM: Brenner tumors – A clinicopathologic
study of benign, borderline and malignant types. J Obstet Gynecol 1981; 1:251.
Aviram M, Blumenfeld Z, Brook J, Lavi A: High-density lipoproteins subfractions in cord blood.
Singapore J Obstet Gynecol 1982; 13:107-114.
Blumenfeld Z, Toledano C, Eitan A, Barzilai A, Brandes JM: Tubo-ovarian abscess in the
postmenopausal women. World J Surg 1982; 6:634-636.
Naor N, Blumenfeld Z, Merzbach D, Timor-Tritsch IE, Seltzer M: Prevalence of group B streptococci
in parturient mothers and their infants. Eur J Pediatr 1982; 138:166-7.
Makler A, Jakobi P, Deutsch M, Blumenfeld Z: Homologous intra uterine insemination with
centrifugated sperm resuspended within umbilical cord serum. Harefuah 1982; 102:137.
Blumenfeld Z, Brook JG, Aviram M, Brandes JM: Changes in lipoproteins and subfractions following
oophorectomy and oestrogen replacement in perimenopausal women. Maturitas 1983; 5:77-83.
Brandes JM, Blumenfeld Z, Beck D, Eshkol A, Levithan E: Correlation of computed  fetoprotein
clearance with actual clearance in a case of endodermal sinus tumour. J Obstet Gynecol 1984; 4:261.
Blumenfeld Z, Kerner H, Thaler I, Deutsch M, Beck D: Increased alpha fetoprotein levels in mixed
mesodermal tumors of ovary. Gynecol and Obstet Invest 1984; 17:169-173.
Thaler I, Timor-Tritsch IE, Blumenfeld Z: Effect of acute hypoxemia on the human fetal heart rate the significance of increased heart rate variability. Acta Ob. Gyn. Scandinavica 1985; 64:47-51.
Blumenfeld Z, Kerner H, Makler A, Eshkol A, Brandes JM: Clinical endocrine and ultrastructural
study of XY-gonadal dysgenesis. J Reprod Med 1985; 30:211.
Blumenfeld Z: Clinical uses of Gonadotropin-releasing hormone (GnRH) and its analogues. BAKI Clinical Biochemistry 1986; 5:170.
Edoute Y, Blumenfeld Z, Aharoni L, and Moskowitz M: Peripartum congestive cardiomyopathy and
endocardial fibroelastosis associated with ritodrine treatment. J Reprod Medicine 1987; 23,10: 793-7.
Andreyko JL, Blumenfeld Z, Marshall LA, Monroe SE, Hricak H, Jaffe RB: Use of an agonistic
analog of Gonadotropin-releasing hormone (Nafarelin) to treat Leiomyomata: assessment by magnetic
resonance imaging. Am J Obstet Gynecol 1988; 158:903-910.
Blumenfeld Z, Makler A, Frisch L, Brandes JM: Induction of spermatogenesis and fertility in
hypogonadotropic azoospermic men by intravenous pulsatile GnRH. Gynecological Endocrinology
1988; 2:151-164.
11
.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
Blumenfeld Z, Nahhas F: Luteal dysfunction in ovulation induction - the role of repetitive human
chorionic gonadotropin supplementation during the luteal phase. Fertil Steril 1988; 50:403.
Blumenfeld Z, Frisch L, Conn PM: Gonadotropin-releasing hormone (GnRH) antibodies formation in
hypogonadotropic azoospermic men treated with pulsatile GnRH - Diagnosis and possible alternative
treatment. Fertil Steril 1988; 50:4. Discussed in the 1990 Yearbook of Infertility, Mosby Yearbook,
Inc.
Blumenfeld Z, Nahhas F: Pretreatment of sperm with human follicular fluid (hFF) for borderline male
infertility. Fertil Steril 1989; 51:863-868.
Blumenfeld Z, Thaler I, Gilhar A: Mode of delivery in Ehler-Danlos syndrome - A reappraisal of the
current status. Int J Dermatology 1989; 28:621-623.
Blumenfeld Z, Lunenfeld B: The potentiating effect of growth hormone on follicle stimulation with
human menopausal gonadotropin in a panhypopituitary patient. Fertil Steril 1989; 52:328-331.
Bronshtein M, Rottem S, Yoffe N, Blumenfeld Z: First and early second trimester diagnosis of nuchal
cystic hygroma by transvaginal sonography: Diverse prognosis of the septated from the non-septated
lesion. American Journal of Obstetrics and Gynecology, 1989; 161:78-82. Discussed in the 1991
Yearbook of Obstetric Gynecology, p. 160.
Bronshtein M, Yoffe N, Brandes JM, Blumenfeld Z: First and early second trimester diagnosis of fetal
urinary tract anomalies using transvaginal sonography. Prenatal Diagnosis 1990; 10:653-666.
Yoffe N, Blumenfeld Z: Gestation and spontaneous delivery in an hydrocephalic patient with
ventriculo-peritoneal shunt. Harefuah 1990; 118:209-210.
Bronshtein M, Rottem S, Yoffe N, Blumenfeld Z, Brandes JM. Early determination of fetal sex using
transvaginal sonography: Technique and pitfalls. J Clin Ultrasound 1990; 18:302-306.
Bronshtein M, Yoffe N, Blumenfeld Z, and Brandes JM: The hair as a sonographic marker of ovarian
teratomas - Improved identification by using transvaginal sonography and simulating model. J Clin
Ultrasound 1991; 19:351-355.
Blumenfeld Z, Yoffe N, and Bronshtein M: Transvaginal sonography in infertility and reproductive
endocrinology. Obstet Gynecol Survey 1991; 46:36-49.
Bronshtein M, Zimmer E, Gershoni-Baruch R, Yoffe N, Meyer , Blumenfeld Z: First and second
trimester diagnosis of fetal ocular defects and associated anomalies: Report of eight cases. Obstet
Gynecol 1991; 77:443-449.
Yoffe N, Bronshtein M, Brandes JM, Blumenfeld Z: Hemorrhagic ovarian cyst detection by
transvaginal sonography: The great imitator. Gynecological Endocrinology 1991;5:123.
Bronshtein M, Mashiah N, Blumenfeld I, and Blumenfeld Z: Pseudoprognathism - An auxiliary
sonographic sign for transvaginal sonographic diagnosis of cleft lip and palate in the early second
trimester. Am J Obstet Gynecol 1991; 165:1314-1316.Surveyed and republished in Search on Obstet
Gynecol 1992; 1:17-19 (Italian).
Brenner B, Blumenfeld Z, Markiewicz W, and Reisner SA: Cardiac involvement in patients with
primary antiphospholipid syndrome. Journal of American College of Cardiology 1991;18: 931-936.
Blumenfeld Z: Growth hormone - A cogonadotropin? Its role in ovulation induction. Journal of InVitro Fertilization and Embryo Transfer 1991; 8:127-136.
Bronshtein M, Blumenfeld Z. First- and early second-trimester oligohydramnios- A predictor of poor
fetal outcome except in iatrogenic olygohydramnios post chorionic villi biopsy. Ultrasound in
Obstetrics and Gynecology 1991; 1(4): 245-249.
Bronshtein M, Lieberson A, Lieberson S, Blumenfeld Z: Clubfeet associated with hydrocephalus New evidence of gradual dynamic development in utero. Obstet Gynecol 1992; 79(suppl): 864-867.
Bronshtein M, Blumenfeld Z: Transvaginal Sonography - Detection of findings suggestive of fetal
chromosomal anomalies by transvaginal sonography in the first and early second trimester. Prenatal
Diagnosis 1992; 12:587-593.
12
.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
Blumenfeld Z, Dirnfeld M, Abramovici H, Amit A, Bronshetein M, Brandes JM: Spontaneous fetal
reduction in multiple gestations assessed by transvaginal ultrasound Br J Ob Gyn. 1992; 99:333-7.
Bronshtein M, Tzidony D, Dimant M, Hajos J, Jaeger M, Blumenfeld Z: Transvaginal sonographic
measurements of the fetal adrenal glands at 12-17 weeks gestation. Am J Ob Gyn 1993;169:1205-10.
Bronshtein M, Yoffe N, Zimmer E, and Blumenfeld Z: Early detection of fetal anomalies by
transvaginal sonography. Fetal and Maternal Medicine Review 1993; 5:137-146.
Makler A, Stoler J, Blumenfeld Z, Feigin PD, Brandes JM: Investigation in real time the effect of
gravitation on human spermatozoa and their tendency to swim up and to swim down. Int J Androl
1993;16:251-7.
Ruach M, Blumenfeld Z: Late onset congenital adrenal hyperplasia - The diversity of the various
diagnostic methods. Harefuah 1993; 124:249-253.
Bronshtein M, Bar-Hava I, Blumenfeld I, Bejar J, Toder V, Blumenfeld Z: The difference between
septated and non-septated nuchal cystic hygroma in the early second trimester. Obstet Gynecol 1993;
81:683-7.
Baruch Y, Weiner Z, Enat R, Ronen A, Blumenfeld Z: Pregnancy after liver transplantation. Int J
Gynecol Obstet 1993; 41:273-276.
Bronshtein M, Weiner Z, Abramovici H, Filmar S, Erlik Y, Blumenfeld Z: Second trimester diagnosis
of fetal gallbladder anomalies by transvaginal sonography - Report of seventeen cases. Prenatal
Diagnosis 1993; 13:851-861.
Blumenfeld Z, Siegler E, and Bronshtein M: The early diagnosis of neural tube defect. Prenatal
Diagnosis 1993;13:863-871.
Bronshtein M, Bar-Hava I, and Blumenfeld Z: Differential diagnosis of the non-visualized fetal
urinary bladder by transvaginal sonography in the early second trimester. Obstet Gynecol
1993;82:490-3.
Bronshtein M, Blumenfeld I, Cohen I, and Blumenfeld Z: Fetal ultrasonographic detection of
hypodontia in the Neu-Laxova syndrome. J Clin Ultrasound 1993; 21:648-50.
Bronshtein M, Amit A, Achiron R, Noy I, Blumenfeld Z: The early prenatal sonographic diagnosis of
renal agenesis: Technique and possible pitfalls. Prenatal Diagnosis 1994; 14:291-297.
Blumenfeld Z, Lorber M, Yoffe N, and Scharf Y: Systemic lupus erythematosus - a predisposition for
uterine cervical dysplasia. Lupus 1994; 3:59-61.
Blumenfeld Z, Bentur L, Yoffe N, Alroy G, Rubin AR: Menstrual asthma - Use of a gonadotropinreleasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma. Fertil Steril
1994; 62:197-200.
Blumenfeld Z: PCO - from basic science to clinical practice. European J Obstet Gynecol and Reprod
Biol 1994; 55:29-30.
Bronshtein M, Blumenfeld I, Kohn J, and Blumenfeld Z: Detection of cleft lip and palate by early
second trimester transvaginal sonography. Obstet Gynecol 1994; 84:73-76.
Blumenfeld Z, Lang N, Kahana L, and Yoffe N: Native GnRH for triggering follicular maturation in
PCOS patients undergoing hMG ovulation induction. Fertil Steril 1994;62:456-460.
Abramovici H, Dirnfeld M, Auslander R, Bornshtein J, Blumenfeld Z, Sorokin Y: Pregnancies
following treatment by GnRH-a (Decapeptyl) and myomectomy in infertile women with uterine
leiomyomata. Int J Fertility 1994; 39:150-155.
Makler A, Poppa E, Rosenberg B, Blumenfeld Z: Investigation in real-time of the effect of
inhalational anesthetics on the motility of human spermatozoa. Isr J Obstet Gynecol 1995; 6:34-40.
Bronshtein M, Zimmer E, and Blumenfeld Z: Transvaginal sonography (TVS) of the fetal urinary
tract. Ultrasonoor Bulletin 1995;19-23.
Blumenfeld Z, Zimmer E, Bronshtein M: The multidirectional sonographic approach to midtrimester
elevated amniotic alpha-fetoprotein or positive acetyl cholinesterase: Transvaginal, transumbilical, and
transabdominal. Obstet Gynecol 1995;86:565-568.
13
.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
Bronshtein M, Zimmer EY, and Blumenfeld Z: Transvaginal sonography (TVS) of the fetal urinary
tract. European Journal of Ultrasound 1996;3:1-7.
Avivi I, Blumenfeld I, Blumenfeld Z: The therapeutic potential of ozone - possible side effects.
Harefuah 1996; Harefuah 1996; 130:327-330.
Bronshtein M., Blumenfeld I., Blumenfeld Z.: The early prenatal diagnosis of cleft lip and the decision
making process for termination of pregnancy. Br J Oral. Maxillofacial Surgery 1996; 34:486-7.
Stahl S, Blumenfeld Z, Yarnitsky D: Carpal tunnel syndrome in pregnancy. Journal of Neurological
Sciences 1996; 136:182-184.
Blumenfeld Z: The role of growth hormone (GH), GH-receptor and GH-binding protein in ovulation
induction and ovarian physiology. Review Article. Isr J Obstet Gynecol 1996; 7:200-210.
Ullmann Y, Blumenfeld Z, Hakim M, Mahoul I, Sujov P, Peled I: Urgent delivery, the treatment of
choice in term pregnant women with extended burn injury. Burns 1997; 23:157-159.
Blumenfeld Z, Shen-Or Z, Har’el H, Jacobson S, Ruach M, Ish-Shalom S, Zinder O: Corticotropinreleasing factor & adrenocorticotropin tests in chronic anovulatory women: Polycystic ovary
syndrome, late onset congenital adrenal hyperplasia,& acanthosis-nigricans.Isr J Ob Gyn1997; 8:158.
Assy N, Blumenfeld Z, Berkovitz D, Nave Y, Kramsky R, Rosenthal E, Enat E, Baruch Y: Long-term
follow-up of liver transplant patients in a nonliver transplantation center. Transplantation Proceedings
1997; 29:2664-2666.
Bronshtein M, Blumenfeld I, Zimmer E, Ben-Ami M, Blumenfeld Z: Prenatal sonographic diagnosis
of nasal malformations. Prenatal Diagnosis 1998;18: 447-454.
Blumenfeld Z, Shabadash V, Shen-Orr Z: Pathophysiology and origin of ascites in ovarian
hyperstimulation syndrome. Assisted Reproduction Reviews 1998; 8:102-110.
Blumenfeld Z, Ritter M, Avivi I, Eibschitz I: Minimizing chemotherapy induced gonadotoxicity - the
role of inhibin-a as a possible marker. Isr J Obstet Gynecol 1998; 9:108-119.
Blumenfeld Z, Amit A, Kerner H, Bronshtein M, Auslander R, Deutsch M: Ovarian calcifications
detection by transvaginal sonography - a possible solitary marker of borderline ovarian malignancy.
Israel J. Obstet. Gynecol. 1998; 9:276-279.
Blumenfeld Z, Blumenfeld I, Bronshtein M: The early prenatal diagonsis of cleft lip and the decision
making process. Cleft Palate - Craniofacial Journal. 1999; 105-107.
Bronshtein M, Blumenfeld Z. Split thalami – possible auxiliary sonographic sign for the early
diagnosis of agenesis of corpus callosum. Israel J Ob Gyn 1999; 10(2):55-58.
Blazer S, Zimmer EZ, Blumenfeld Z, Zelikovic I, Bronshtein M: Natural history of fetal simple renal
cysts detected in early pregnancy. J Urol 1999; 162:812-814.
Dirnfeld M, Bider D, Abramovici H, Calderon I, Blumenfeld. Subsequent successful pregnancy and
delivery after intracytoplasmic sperm injection in a patient with XY gonadal dysgenesis. Europ J
Obstet Gynecol Reprod Biol 2000, 88:101-102.
Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian
function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated
by chemotherapy. Lupus. 2000; 9(6):401-5.
Lobushitzky R, Levy M, Shen-Or Z, Blumenfeld Z Herer P, Lavie P, Long-term melatonin
administration does not alter pituitary gonadal hormone secretion in normal adult men. Human Reprod
2000:15:60-65.
Blumenfeld Z. Hirsutism – evaluation and treatment. Isr Med Assoc J. 2000; 2:632-634.
A,B,C,D- Blumenfeld Z.: GnRH- Antagonists instead of agonists: Change a common practice for a
better-not for merely a newer one. Fertility Sterility 2001: Vol 76:443-4.
A,D- Weiner Z, Younis J.S, Blumenfeld Z, Shalev E: Assessment of uterine placental circulation in
thrombophilic women. Seminars in Thrombosis & Hemostasis. 2003; 29: 213-8.
A,B,C,D- Blumenfeld Z.Gynecologic Concerns for young women exposed to gonadotoxic
chemotherapy. Curr Opin Obstet Gynecol. 2003; 15: 359-70.
14
.
139.
140.
A,D- De Schepper J, Schiettecatte J, Veldeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert
E, Smitz J, Verdoodt P, Hooghe R, Hooghe-Peters E: Clinical and biological characterization of
macroprolactinemia with and without prolactin-IgG complexes. Eur J Endocrinol. 2003 Sep; 149:2017.
A,B,C,D- Quint EH, Breech L, Blumenfeld Z. Case 2005: ovarian suppression with chemotherapy in
adolescents. J Pediatr Adolesc Gynecol. 2004 Dec; 17(6):413-6.
141.
A,D- Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J; LIVE-ENOX Investigators. Efficacy and
safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the
LIVE-ENOX study. J Thromb Haemost. 2005 Feb;3(2):227-9.
142.
A,C,D- Bronshtein M, Arad A, Solt I, Blumenfeld Z. Pilonidal Sinus- The Tale of the Fetal Tail.
European Journal of Obstetrics& Gynecology& ReproductiveBiology.2005;119:255-6
143.
A,B,C,D- Dann EJ, Epelbaum R, Haim N, Ben Shahar M, Rowe JM, Blumenfeld Z.: Fertility and
ovarian function are preserved in women treated with an intensified regimen of
cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for Non Hodgkin
Lymphoma.Human Reprod. 2005; 20:2247-9.
144.
A,B,C,D- Blumenfeld Z, Eckman A.
Medicina Reproductiva 2005; 11:33-43.
145.
A,B,C,D- Blumenfeld Z, Eckman A. Preservacion de la ferdilidad y la funccion ovarica y
minimizacion de la gonadotoxicidad inducida por la quimiotherapia en mujeres jovenes. Medicina
Reproductiva 2005; 11:57-76.
146.
A,B,C,D- Blumenfeld Z, Eckman A.Preservation of Fertility by Gonadotropin-Releasing Hormone
Agonists. GnRH-Agonisten und Ovarschutz. 2005; Der Gynäkologe; Suppl 1:S42-51.
147.
A,B,C,D- Blumenfeld Z – Invited Chapter Editor on:”Fertility Drugs, IVF and the risk of
Gynaecologic Malignancies.” Chapter Editor’s
Introduction- CME Journal of Gynecologic
Oncology 2005; 9: 235-264.
148.
A,B,C,D- Lowenstein L, Solt I, Blumenfeld Z – Invited Chapter Editor on ART and Gynecologic
Cancer: Drawbacks of Assisted Reproductive Technology in the Offsprings: retinoblastoma,
Beckwith-Wiedemann, and Angelman syndromes. CME Journal of Gynecologic Oncology 2005;
9: 253-5.
149.
A,B,C,D- Blumenfeld Z – Invited Chapter Editor on ART and Gynecologic Cancer. Drawbacks of
Assisted Reproductive Technology-Chapter Editor’s Conclusions - CME Journal of Gynaecologic
Oncology 2005; 9: 264.
150.
A,D- Sarig, Z. Blumenfeld, R. Leiba, N. Lanir, B. Brenner. Modulation of Systemic Hemostatic
Parameters by Low Molecular Weight Heparin during Gestation of women with Pregnancy Loss.
Thromb Haemost. 2005 Nov; 94(5):980-5.
151.
A,B,C,D- Blumenfeld Z, Lowenstein L, Brook O, Gonen R, Ophir E, Samueloff A. "Does
Maternal Height Affect Triplets' Birth Weight?". Med Sci Monit. 2006;12:CR40-43.
152.
A,D- Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann EJ, Blumenfeld Z, Abraham A,
Manor Y, Shpilberg O, Lishner M. Fertility status among women treated for aggressive nonHodgkin’s lymphoma. Leukemia & Lymphoma 2006; 47:623-7.
A,D- Sarig G, Aberbach I, Schliamser L, Blumenfeld Z, Brenner B. Evaluation of ProC Global
assay in women with a history of venous thromboembolism on hormonal therapy. Thromb
Haemost. 2006; 96: 578-83.
A,B,C,D- Blumenfeld Z, Boulman N, Leiba R, Siegler E, Shahar S, Linn R, Levy Y. High Creactive protein Levels are associated with Oral Hormonal Menopausal Therapy but Not with
Intrauterine Levonorgestrel and Transdermal Estradiol.“The Scandinavian Journal of Clinical &
Laboratory Investigation.” 2007; 67:257-63. Cited in the NEJM Journal Watch among
important papers of the year.
153.
154.
Tratamientos oncologicos y supervivencia folicular.
15
.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
A,B,C,D- Blumenfeld Z. Gender difference: fertility preservation in young women but not in men
exposed to gonadotoxic chemotherapy. Minerva Endocrinol. 2007; 32:23-34. Review.
Blumenfeld Z., I. Avivi, Eckman, R. Epelbaum, J.M. Rowe, E.J. Dann. Gonadotropin Releasing
Hormone Agonist Decreases Chemotherapy Induced Gonadotoxicity and Premature Ovarian
Failure in Young Female Patients With Hodgkin Lymphoma. Fertil Steril. 2008;89:166-73.
B,D- Sills ES, Qublan HS, Blumenfeld Z, Dizaj AV, Revel A, Coskun S, Jaoude IA, Serour G,
Eskandar M, Khalili MA, Demirol A, Trokoudes K, Ocal P, Sultan AM, Lotto BA, El-Kareh
A.Regional clinical practice patterns in reproductive endocrinology: A collaborative transnational
pilot survey of in vitro fertilization programs in the Middle East. 1: J Exp Clin Assist Reprod.
2007 Aug 28;4(1):3 [Epub ahead of print].
A,B,C,D- Blumenfeld Z. Debate: How to preserve fertility in young women exposed to
chemotherapy? The role of GnRH-agonist in addition to cryopreservation of embryos, oocytes, or
ovaries. The Oncologist 2007; 12:1044–1054. Selected for CME- Continued Medical Education
Manuscript.
A,B,C,D- Blumenfeld Z. .‫ שימור פוריות בחולות החשופות לכימותרפיה‬In Hebrew. Cancer
Medicine. 1.9. 2007; 5:14-17.
A,B,C,D- Blumenfeld Z. .‫ שימור פוריות בחולות החשופות לכימותרפיה‬In Hebrew. Ob. Gyn.
Medicine. . 1.5.2008.
A,B,C,D- Blumenfeld Z and von Wolff M. GnRH-analogues and oral contraceptives for fertility
preservation in women during chemotherapy. Human reproduction Update.2008;14:543-52.
A,B,C,D- Blumenfeld Z. Editorial—Recent Developments in Clinical Medicine: Reproductive
Health. Clinical Medicine: Reproductive Health 2008:2 1-3. 14 Jul 2008
A,B,C,D- Blumenfeld Z. GnRH-agonists in fertility preservation. Current Opinion in
Endocrinology, Diabetes, and Obesity. 2008 Dec; 15(6):523-8.
A,B,C,D- Blumenfeld Z, Abdallah W, Sela-Guttmann O, Brook OR. Triplet GestationPrevention, Risks, & Management Dilemmas. The Open Women’ Health Journal, 2008, 2, 11-21.
A,B,C,D- Blumenfeld Z, Abdallah W, Kaplan D, Nevo O. Endometrial thickness- a practical
prospective marker for the risk of surgical intervention after RU486 induced abortion. Clinical
Medicine: Reproductive Health. 2008:2; 25–30.
A,B,C,D- Blumenfeld Z. Premature ovarian failure: etiology and possible prevention. Expert
Review of Endocrinology & Metabolism 2009; 4:173-181.
2009 .‫מדיסין‬
/ . ‫ אטיולוגיה ומניעה אפשרית‬- ‫ אי ספיקה שחלתית מוקדמת‬- ‫זאב בלומנפלד‬
168.
C,D- Bronshtein M, Khatib N, Blumenfeld Z, Prenatal Diagnosis and Outcome of Isolated
Interrupted Inferior Vena Cava. Amer. J. Obstet. Gynecology. Am. J. Obstet. Gynecol. 2010;
202:398.e1-4.
169.
A,B,C,D- Blumenfeld Z, Zuckerman T. Repeated spontaneous pregnancies and successful deliveries
after repeated autologous stem cell transplantation and GnRH-agonist. Oncologist. 2010; 15:59-60.
C,D- Younis, J, Shukha, M, Ben-Ami, M , Izhaki, I , Blumenfeld, Z , Brenner, B, Sarig G.
Prospective Evaluation of the Protein C Global Assay during Pregnancy Following Assisted
Reproduction. Obstet.Gynecol. 2010;115: 969-74.
A,B,C,D -Blumenfeld Z. Fertility Treatment in Women with Premature Ovarian Failure. Expert
Rev. Obstet. Gynecol. 2011; 6; 321–330.
Blumenfeld Z, Mischari O, Schultz N, Boulman N, Balbir-Gurman A. Gonadotropin Releasing
Hormone Agonists May Minimize Cyclophosphamide associated Gonadotoxicity in SLE and
Autoimmune Diseases. Semin Arthritis Rheum. 2011;41: 346-52
Bronshtein M, Zimmer Z, Blazer S, Blumenfeld Z. Right Ductus Arteriosus- Facts and Theory. Eur J
Obstet Gynecol. 2011; 159: 282–288.
Dann EJ, Blumenfeld Z, Bar-Shalom R, Avivi I, Ben-Shachar M, Goor O, Libster D, Gaitini D, Rowe
JM, Epelbaum R. A 10-year experience with treatment of high and standard risk Hodgkin disease: Six
170.
171.
172.
173.
174.
16
.167
.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
Am J Hematol. 2012 ;( 87)1:32-6.
Blumenfeld Z. Chemotherapy and Fertility. Best Pract Res Clin Obstet Gynaecol.2012; 26: 379–90.
Zimmer Z, Blazer S, Blumenfeld Z, Bronshtein M. Fetal Transient Clitoromegaly and Transient
Hypertrophy of Labia Minora in Early and Mid Pregnancy. J Ultrasound Med. 2012; 31:409-15.
Blumenfeld Z. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian
function. Oncologist. 2012; 17:162-3.
Bronshtein M, Zimmer EZ, Blazer S, Blumenfeld Z. Transient abnormal fetal cardiac flow patterns at
13 to 17 gestational weeks. Prenat Diagn. 2012; 32:444-9.
Blumenfeld Z. Epigenetics and vitrification of embryos: one step forward and many raised equivocal
questions. Fertil Steril. 2012; 98: 41-2. Invited Commentary on "Effect of 5-aza-2'-deoxycytidine on
methylation of the putative imprinted control region of H19 during the in vitro development of
vitrified bovine two-cell embryos".
Blumenfeld Z. GnRH-a for Preservation of Ovarian Function during (Neo) Adjuvant Chemotherapy
for Breast Cancer" - J Clin Oncol. 2012; 30:3310.
Blumenfeld Z, Patel B, Leiba R, Zuckerman T. Gonadotropin Releasing Hormone agonist may
minimize premature ovarian failure in young women undergoing autologous stem cell transplantation.
Fertil Steril, 2012; 98: 1266-70
Khatib N, Blumenfeld Z, Bronshtein M. Early Prenatal Diagnosis of Tricuspid Stenosis," Am J Obstet
Gynecol. 2012;207(5):e6-8.
Blumenfeld Z. Preservation of ovarian function and fertility despite gonadotoxic chemotherapy.
Expert Review Endocrinol Metabol 2012; 7: 567-76.
Tripto-Shkolnik L, Blumenfeld Z, Bronshtein M, Salmon A, Jaffe A. Pregnancy in a Patient with
Adrenal Carcinoma Treated with Mitotane: A Case Report and Review of Literature. J Clin
Endocrinol Metab. 2013; 98: 443-7.
Blumenfeld Z, Katz G, Evron A. "An ounce of prevention is worth a pound of cure"- The case for and
against GnRH-agonist for fertility preservation. Annals of Oncology, 2014,March. [Epub ahead of
print]
Blumenfeld Z, Khatib N, Zimmer EZ, Bronshtein M. Fetal demise in the early second trimester:
sonographic findings. J Clin Ultrasound. 2014 Jul 3. [Epub ahead of print]
Bronshtein M, Solt I, Blumenfeld Z. [The advantages of early midtrimester targeted fetal systematic
organ screening for the detection of fetal anomalies--will a global change start in Israel?]. Harefuah.
2014;153:320-4, 368. Hebrew.
In Press/Accepted PAPERS
 Orli Turgeman, Ilan Calderon, Martha Dirnfeld, Mada Hashem, Zeev Blumenfeld. "Sphingosine1-Phosphate may decrease the cytotoxic effect of Doxorubicin on human granulosa cells". In
Press, 2014, Journal of Cell Science & Therapy (JCEST).
 Olivia M Diamond, Orli Turgeman, Zeev Blumenfeld. Minimizing the Doxorubicin-Induced
Gonadotoxicity by Sphingosine-1-Phosphate analogue FTY720. In Press, Am J Clin
Experimental Obstet Gynecol- AJCEOG.
SUBMITTED PAPERS
 Gabi Kaidar, Zeev Blumenfeld, Nehama Zuckerman-Levin, Elena Dumin, Carlos Knopf, Ze'ev
Hochberg. Steroid-Metabolizing Enzymes in Polycystic Ovary Syndrome. Europ J. Endocrinol.
Submitted 2014.
 Tereshenkov I.K, Knopf C, Blumenfeld Z, Lahav M. Interference of Androgenic Metabolites with
Steroidogenesis in Human Adrenal Tumor Cells (H295R).
 Blumenfeld Z, Letter to the editor - "GnRH-Agonists for Fertility Preservation". Submitted to
Curr Breast Cancer Rep
17
.
CHAPTERS IN BOOKS
1. Blumenfeld Z, Rottem S, Elgali S, and Timor-Tritsch IE: Transvaginal assessment of early embryologic
development. In: Transvaginal Sonography, eds. I.E. Timor-Tritsch, S. Rottem. Elsevier Science Publishing
Company, Inc., 1988; pp. 87-108.
2. Timor-Tritsch IE, Rottem S, Blumenfeld Z: Pathology of the early intrauterine pregnancy. In: Transvaginal
Sonography, eds. I.E. Timor-Tritsch, S. Rottem. Elsevier Science Publishing Company, Inc., 1988; pp. 109124.
3. Drugan A, Blumenfeld Z, Erlik Y, Timor-Tritsch IE, Brandes JM: The use of transvaginal sonography in
infertility. In: Transvaginal Sonography. Timor-Tritsch IE,Rottem S (eds.), Elsevier Science Publishing
Company, Inc.,1988, pp.143-159.
4. Blumenfeld Z, Makler A, Frisch L, Brandes JM: Induction of spermatogenesis and fertility in
hypogonadotropic azoospermic men by intravenous pulsatile GnRH. Proceedings of the 1st Congress of the
International Society of Gynecologic Endocrinology, Crans Montana, Switzerland, March 1-7, 1988.
Parthenon Press, New Jersey, USA. Edited by Genazzani AR, Petraglia F, Volpe A, Facchinetti F, 1988, pp.510.
5. Blumenfeld Z, Nahhas F: Luteal dysfunction in ovulation induction - the role of repetitive human chorionic
gonadotropin supplementation during the luteal phase. Proceedings of the 1st Congress of the International
Society of Gynecologic Endocrinology, Crans Montana, Switzerland, March 1-7, 1988. Parthenon Press,
New-Jersey, USA. Edited by Genazzani AR, Petraglia F, Volpe A, Facchinetti F, 1988, pp. 329-333.
6. Blumenfeld Z, Dirnfeld M, Beck D, Abramovici H, Brandes JM: Comparison of treatment of uterine
leiomyomata with 3 GnRH agonistic analogues - Efficacy and side effects. Proceedings of the International
Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, Switzerland, 1988, MTP
Press, Lancester, 1989, pp. 45-52.
7. Blumenfeld Z, Lunenfeld B, Brandes JM: The permissive role of growth hormone in ovulation induction with
human menopausal gonadotropin. In: Advances in Assisted Reproductive Technologies. Mashiach S, BenRafael Z, Laufer N, Shenker J, eds. New-York: Plenum Press, 1990, pp. 397-408.
8. Timor-Tritsch IE, Blumenfeld Z, Rottem S: Sonoembryology. In: "Transvaginal Sonography", ed. TimorTritsch IE, Rottem S. 2nd ed. 1991. New-York: Elsevier, pp. 225-298.
9. Blumenfeld Z, Thaler I, Weiner Z, Beck D, Brandes JM: Treatment of uterine leiomyomata with GnRH
analogue (Nafarelin): A clinical protocol of interrupted (on and off) treatment. In: "Advances in the Study of
GnRH Analogues", Vol. 4 - GnRH Analogues and Cancer, ed. B. Lunenfeld. Proceedings of the 2nd
International Symposium on GnRH Analogues. London: Parthenon Publishing Group Limited, 1991; pp. 123131.
10. Blumenfeld Z, Brandes JM, and Bronshtein M: Ultrasonography of abnormal early pregnancy. In: The First
Twelve Weeks of Gestation, Heidelberg: Springer Verlag, 1992, pp. 358-375.
11. Abramovici H, Dirnfeld M, Auslander R, Sorokin Y, Blumenfeld Z: Pregnancies following treatment by
GnRH-a (Decapeptyl) and myomectomy in infertile women with uterine leiomyomata. In: GnRH Analogues
and Cancer, edited by B. Lunenfeld, Vol. 4, Parthenon Publishing Co., 1992, pp. 119-122.
12. Blumenfeld Z: Treatment of uterine leiomyomata by LH-RH agonists. In: K. Hoffken, ed., "Peptides in
Oncology: LH-RH Agonists and Antagonists", Berlin: Springer Verlag, 1992, pp. 19-31.
13. Blumenfeld Z, Amit T: The Role of GH in Ovulation Induction. In: Molecular and Clinical Advances in
Pituitary Disorders - 1993. S. Melmed, ed., Proceedings of the 3rd International Pituitary Congress. Endocrine
Research and Education, Inc., Los Angeles, CA. pp. 205-210, 1994.
14. Bronshtein M, Blumenfeld Z: Ultrasound and Down Syndrome In: J.G. Grudjinskas, T. Chard, M. Chapman
and H. Cuckle (eds.), Screening for Down's Syndrome, Chapter 12, 1994, Cambridge University Press, pp.
181-193.
18
.
15. Bronshtein M, Zimmer E, Gershoni R, Yoffe N, Meyer H, Blumenfeld Z: First and second trimester fetal
occular defects. In: S. Matsumoto, K. Sato, N. Tamaki, S. Oi (eds.), Annual Review of Hydrocephalus, Vol.
10, Neuron Publishing Co. Ltd., 1992, pp. 56-57.
16. Blumenfeld Z, Bronshtein M: Spontaneous embryo and fetal reduction and the early detection of fetal
anomalies using transvaginal sonography. In: Implantation and Early Pregnancy in Humans, edited by ER
Barnea, JH Check, JG Grudjinskas and T Marou, London: Parthenon Publishing Group, 1994, pp. 435-463.
17. Blumenfeld Z: New applications and indications for native gonadotropin-releasing hormone (GnRH) and for
GnRH analogues (GnRH-a). In: Infertility and Transvaginal Sonography - Current Concepts, edited by S.
Desai, G. Allahbadia, New Delhi: Jaypee Medical Publisher Ltd, 1995, pp. 47-54.
18. Zimmer EZ, Blumenfeld Z, Bronshtein M: The Fetal Eye. In: Ultrasonography of the Prenatal and Neonatal
Brain, edited by: IE Timor-Tritsch, AC Monteagudo, H Cohen. Appleton and Lange. 1996, Chapter 10, pp.
333-346.
19. Bronshtein M, Blumenfeld Z: Spontaneous evolution of fetal malformations detected in the first trimester. In:
Ultrasound in the First Trimester of Pregnancy, edited by E. Jauniaux, Barnea E, Edwards RG. Pp365-375.
1997.
20. Bronshtein M, Zimmer E, and Blumenfeld Z: Early midtrimester transvaginal sonography for the detection of
chromosomal abnormalities. In: Transvaginal Sonography, edited by I.E. Timor-Tritsch and S. Rottem, edition
3, Chapman-Hall.
21. Blumenfeld Z, Bronshtein M: Detection of fetal dyskaryosis by midtrimester transvaginal sonography. In:
Transvaginal Sonography in Infertility, 1998. Edited by G. Allahbadia, Rotunda Med. Technologies Pvt Ltd,
Bombay, India pp 393-405.
22. Bronshtein M, Blumenfeld Z, and Zimmer E: Early detection of fetal malformations with transvaginal
sonography. In: Transvaginal Sonography, edited by I.E. Timor-Tritsch and S. Rottem, edition 3, ChapmanHall, 1998.
23. Bronshtein M, Zimmer EZ, and Blumenfeld Z: Early sonographic detection of fetal anomalies. In: Kurjak A
(ed.), Textbook of Perinatal Medicine. Parthenon Publishing, 1998, Lancaster, UK, pp 263-281.
24. Blumenfeld Z, Shabadash V, Shen-Orr Z: The ovary as the origin of OHSS. In: "Pathophysiology of OHSS",
Ed: A. Pellicer, C. Simon, F. Bonilla-Musoles, J. Remohi. Serono Symposia Publications, Vol. 4, 1999:69-88.
25. Blumenfeld Z: A rationalized treatment for OHSS. In: "Pathophysiology of OHSS", Ed: A. Pellicer, C. Simon,
F. Bonilla-Musoles, J. Remohi. Serono Symposia Publications, Vol. 4, 1999:185-196.
26. Blumenfeld Z, Bronshtein M. Chromosomal abnormalities. In: Transvaginal sonography of the fetus in early
pregnancy. Parthenon Publishing2000 p 195-209.
27. Blumenfeld Z, Zimmer E, Weizmanm B, Bronshtein M. Central nervous system.Chromosomal abnormalities.
In: Transvaginal sonography of the fetus in early pregnancy. Parthenon Publishing, 2000 p 41-65.
28. Blumenfeld Z, Weizman B, Talmon R, Bronshtein M. The fetal urinary tract. . In: Transvaginal sonography of
the fetus in early pregnancy. Parthenon Publishing. 2000 p 165-187.
29. Blumenfeld Z. Ovulation induction by gonadotropins. Chapter in book “Ovulation Induction”, ed. Gautam
Allahbadiah, Rotunda Press, Mumbay. India, 2000: 27-45.
30. Bronshten M, Z. Blumenfeld Valor de la ecografia transvaginal dirigidarealizada por un ecografista experto al
inicio del segundo trimestre paradeteccion de malformaciones fetales. “Cuadernos De Medicina Reproductuve
Editor: A. Pellicer, C. Simon V. Serra-Serra, Editorial Medica Panamercina Madrid 2001 p 103-120 Vol 7 No
1.
31. Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy-associated
gonadotoxicity and premature ovarian failure: the role of inhibin- A and – B as markers “Advances in
Gynecological Endocrinology” Edited by A.R. Genazzani and F. Petraglia. Parthenon Publishing.
32. Blumenfeld Z. The Endocrinology of ART. In: The Art & Science of Assisted Reproductive Techniques
(ART); Editors: Gautam Allahbadia & Rita Basuray. Jaypee Brothers Medical Publishers (P) Ltd. New Delhi.
2003. Pp: 6-14.
19
.
33. Blumenfeld Z. Ovarian Tissue Cryopreservation in Cancerous Patients: State of the Art. In: The Art & Science
of Assisted Reproductive Techniques (ART); Editors: Gautam Allahbadia&Rita Basuray. Jaypee Brothers
Med. Pub. New Delhi. 2003. Pp: 320-32.
34. Blumenfeld Z. The Patient with Systemic Lupus Erythematosus. In: IVF in the medically complicated
patient: a guide to management. Ed. Nick S. Macklon. Taylor & Francis. London 2005. Pp: 51-60.
35. Blumenfeld Z. ‫מחלות קולגן ורקמות חיבור בהריון‬. In Hebrew. Ed- A. Golan.. 2008
36. Blumenfeld Z. ‫שמירת פוריות בנשים החשופות לכימותרפיה‬. In Hebrew. Ed- A. Golan. 2008.
37. Blumenfeld Z. Quimoprevencion. In:"Preservacion de la fertilidad en la paciente oncologica", Editor:
Justo Calejjo Olmos. Editorial glosa,S.L. , ANGELINI. Barcelona, Spain. 2009. Pp:57-88.
1.
2.
3.
4.
5.
6.
7.
8.
9.
LETTERS TO THE EDITOR
Blumenfeld Z: Letter to the Editor. Fertil Steril 1989; 51:549-550.
Blumenfeld Z: Neurological symptoms related to gonadotropin-releasing hormone agonist, low estrogen, or?
Letter to the Editor. Fertil Steril 1990; 54:1185-1186.
Blumenfeld Z, Bronshtein M: Letter to the Editor. Am J Obstet Gynecol 1990; 163:268-269.
Blumenfeld Z: Role of growth hormone in ovulation induction. Letter to the Editor. Fertil Steril 1994; 62:204205.
Blumenfeld Z, Linn S: Corpus luteum dysfunction - is the treatment really ineffective? Letter to the Editor.
Am J Obstet Gynecol 1994; 170:958.
Blumenfeld Z, Avivi I: Effect of systemic hyperandrogenism on the adrenal response to ACTH. Letter to the
Editor. Fertil Steril 1994; 62:1096-1097.
Blumenfeld Z: Long lives the small difference. Letter to the Editor. Am J Obstet Gynecol 1994; pp. 16731674.
Blumenfeld Z: Menstrual asthma - therapy? Letter to the Editor. Fertil Steril 1995; 63:1131.
Bronshtein M, Blumenfeld Z: A potential danger of obstetric ultrasound - husband's head trauma. Letter to the
Editor. Ultrasound Obstet Gynecol 1995; 5:422-423.
10. Blumenfeld Z: Lipids and Finasteride. Letter to the Editor. Fertil Steril 1996; 65: 677-678.
11. Bronshtein M, Nussem D, Blumenfeld Z: Anaphylaxis to latex - a possible danger of transvaginal ultrasound.
Letter to the Editor. Ultrasound Obstet Gynecol 1996; 7:379-380.
12. Blumenfeld Z: Adverse effects of high serum E2 levels on conception? - A possible explanation to the debate.
Letter to the Editor. Fertil Steril 1996; 66:1043-1044.
13. Blumenfeld Z, Avivi I: Detection of CAH heterozygotes. Letter to the Editor. Fertil Steril 1997; 68:182-184.
14. Blumenfeld Z. : Provocative testing with ACTH interpretation. Letter to the Editor. Fertil Steril 1998; 69:3589.
15. Blumenfeld Z: Preservation of ovarian function during chemotherapy. Letter to the Edittor - Harefuah. 1998,
135: 482.
16. Blumenfeld Z, Avivi I. "Prevention of Chemotherapy ovarian damage - Primum Non Nocere". Letter to the
Editor. Fertil Steril. April 1999; 71:773-775.
17. Blumenfeld Z, Blumenfeld I, Bronshtein M: The early prenatal diagnosis of cleft lip – letter to the Editor.
Response. Cleft Palate Cranio Fac J. 1999; 36:105-107.
18. Blumenfeld Z. Recombinant FSH vs. urinary FSH-retrospective study of matched pairs for type of treatment
(IVF or ICSI). .Fertil Steril.2001; 76:1289-90.
19. Blumenfeld Z: Ovarian function in an adult woman with McCune-Allbright Syndrome. Letter to the Editor J.
Clin. Endocrinol. Metab.2001; 87(3): 1431.
20. Blumenfeld Z. Letter to the editor. Trends in Endocrinology and Metabolism. 2002.
20
.
21. Blumenfeld Z. Treatment with gonadotropin-releasing hormone agonists and prevention of multiple
gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: Comment on
the article by Guballa et al. Letter to the editor. Arthiritis & Rheumatism, 2002; 46:2542.
22. Blumenfeld Z. Confirmation needed for follicular fluid estradiol levels in different ovarian stimulation
protocols. Letter to the editor. Human Reproduction. 2002; 17: 1671.
23. Blumenfeld Z.Comment on steroid hormones and disease activity during pregnancy in systemic lupus
erythematosus. Letter to the editor. Arthritis & Rheumatism (Arthritis Care & Research) 2002; 47(6): 6912.December 15.
24. Blumenfeld Z. Effect of FSH priming on response to hCG in subjects with follicle stimulating hormone
receptor (FSHR) mutations. Fertil Steril.2003; 79:238-9.
25. Blumenfeld Z. In syndromes of confused gonads, height can be important. Fertil Steril. 2003 Feb; 79(2):
461
26. Blumenfeld Z, Dann EJ. Reply to Letter to the Editor on "Fertility after treatment for Hodgkin's disease",
by M. K. Bohlmann, M. von Wolff & T. Strowitzki et al. Ann Oncol 2003; 14: 499.
27. Blumenfeld Z. Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum nonnocere. Hum Reprod 2004; 19: 1924-1925.
28. Blumenfeld Z., Benarush M, Zuckerman T. Spontaneous pregnancy and normal delivery after repeated
autologous bone marrow transplantation and GnRH-agonist treatment. Hum Reprod. 2007; Aug;
22(8):2346.
29. Blumenfeld Z. Pregnancies in patients with POF gonadotropin stimulation and pretreatment with ethinyl
estradiol. Fertil Steril. 2007 Sep; 88(3):763.
30. Blumenfeld Z. "Reduced Serum Testosterone Levels in Infant Boys". Journal of Clinical Endocrinology
& Metabolism. Oct.24th, 2007.
31. Blumenfeld Z. "Decision thresholds" for premature LH surges? Fertil Steril. 2007 Dec;88(6):1709.
32. Blumenfeld Z. Incorrect units can lead to misinterpretation and error. Fertil Steril. 2008; 90:460-1. Epub
2008 Jun 25.
33. Blumenfeld Z. Maternal thyroid hypofunction and pregnancy outcome. Obstet. Gynecol. 2008 Dec;
112(6):1390-1.
34. Blumenfeld Z. Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH
agonists? Fertil Steril. 2008 Nov 29. [Epub ahead of print]
35. Blumenfeld Z. Transplantation of ovarian tissue-still incomplete data. Hum Reprod Febr.4.2009.
36. Blumenfeld Z. Gonadotropin-releasing hormone analogues in fertility preservation-"Evidence-based
medicine or just a theory?" Fertil Steril. 2009 May 22. [Epub ahead of print].
37. Blumenfeld Z. The beneficial role of gonadotropin releasing hormone agonists on fertility preservation.
Pediatric Blood Cancer. 2009; 53:1159.
38. Blumenfeld Z. Preservation of Fertility in Patients with Cancer-Letter to the editor. New-England J.
Medicine, 2009; 360; 25: 2680-1.
39. Blumenfeld Z. Ovarian Function Preservation by GnRH Agonists during Chemotherapy. J Womens
Health (Larchmt). 2009 ; 18: 1471.
40. Blumenfeld Z. "It ain't necessarily so". Fertil Steril. 2009; 92:e65.
41. Blumenfeld Z. "Fertility preservation and GnRH-a for chemotherapy- debate", Arch Gynecol Obstet.
2010; 282: 585-6.
42. Blumenfeld Z. "Fertility preservation after chemotherapy for Hodgkin lymphoma". Hematol Oncol. 2011;
29: 52.
43. Blumenfeld Z. Pharmacological interventions for fertility preservation during chemotherapy. Breast
Cancer Res Treat. 2011; 125: 289-90.
21
.
44. Blumenfeld Z. ZORO Study: Discrepancy between the conclusion and the results. J Clin Oncol. 2011; 29:
3340.
45. Blumenfeld Z. Unnecessary life threatening complications after IVF in mixed connective tissue disease. J
Assist Reprod Genet 2012; 29:573.
46. Blumenfeld Z. Gonadotropin-releasing hormone agonist for preservation of ovarian function during
(neo)adjuvant chemotherapy for breast cancer. J Clin Oncol. 2012; 30:3310;
47. Blumenfeld Z. Fertility preservation. Clin Endocrinol (Oxf). 2012; 76:919-20.
48. Blumenfeld Z & Dann EJ. GnRH Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure
in Lymphoma. J. Clin Oncology. 2013; 31:3721.
49. Blumenfeld Z. The Safety of Transplanting cryopreserved Ovarian Tissue in Cancer Patients International
Society for Fertility Preservation. January 2014.Volume 2 Issue 2.
50. Blumenfeld Z. Comment on: sexual and fertility adverse effects associated with chemotherapy treatment
in women. Expert Opin Drug Saf. 2014 Aug 8:1-3. [Epub ahead of print]
51. Blumenfeld Z. Fertility preservation and GnRHa for chemotherapy: debate. Cancer Manag Res. 2014
Aug 19;6:313-5. doi: 10.2147/CMAR.S66600. eCollection 2014.
Active Participation and Presentations in International Scientific Meetings
1.
Second International Congress of Andrology, Tel Aviv, Israel. Sperm viability as affected by change
of pH and osmolarity of semen and urine specimens. Follow up of various treatments of infertile men
by objective evaluation of sperm quality, 1981.
2.
Fifth World Congress of Sexology, Jerusalem, Israel. The relationship between libido and blood
testosterone levels, 1981.
3.
Annual Meeting of the American Fertility Society, New Orleans, LA. An improved sperm
immobilization test based on multiple exposure photography, 1984.
4.
Annual Meeting of the Society for Gynecologic Investigation, Phoenix, AZ. CRF can stimulate ACTH
secretion in human fetal pituitary glands during the first half of pregnancy. Consideration in
developing a clinically useful GnRH agonist for contraception. Treatment of hirsutism with a GnRH
agonist. Late follicular LH patterns predict preovulatory LH surge in ovulation induction, 1985.
5.
Annual Meeting of the Endocrine Society, Baltimore, MD. Modulation of human fetal pituitary ACTH
by CRF, AVP, cAMP, corticoids and catecholamines, 1985.
6.
American Fertility Society Annual Meeting, Chicago, IL. Comparison of the incidence of premature
ovulation with different stimulation protocols in an IVF program, 1985.
7.
IVth Franco-Israeli Colloqvium of Gynecology and Obstetrics, Jerusalem. Detection of antisperm
antibodies - a cytotoxicity immobilization test. The predictive value of LH values for premature LH
surge in an IVF program. GnRH agonist (Nafarelin) for ovulation suppression - clinical consideration
and side effects. Systemic Lupus Erythematosus (SLE) and pregnancy: The reciprocal effect between
the disease and gestation, 1985.
8.
IVth International Symposium on Ultrasound, Tel-Aviv, Israel. Sonographic anatomy and embryology
of the early pregnancy, 1986.
9.
Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada. Chronic exposure of
cultured human fetal pituitary cells to GRF causes partial loss of responsiveness to GRF. Treatment of
uterine leiomyomata with a GnRH agonist, 1986.
10.
Annual Meeting of the Society for Gynecologic Investigation, Atlanta, GA. Induction of
spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile GnRH,
1987.
11.
Vth International Congress on In-Vitro Fertilization and Embryo Transfer, Norfolk, VA. Identical
twins, spontaneous absorption of multiple fetuses and IVF, 1987.
12.
International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva,
Switzerland. Invited lecture - Development of antibodies against GnRH in patients treated with
22
.
pulsatile GnRH. Comparison of treatment of uterine leiomyomata with 3 GnRH agonists analogs efficacy and side effects, 1988.
13.
International Congress of the Society of Gynecologic Endocrinology, Crans-Montana, Switzerland
(invited speaker). Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by
intravenous pulsatile GnRH, 1988.
14.
International Workshop on Maternal Early Recognition of Pregnancy, Jerusalem, Israel. Luteal
dysfunction in ovulation induction - the role of repetitive chorionic gonadotropin supplementation
during the luteal phase, 1988.
15.
VIth International Congress of In-Vitro Fertilization and Assisted Reproduction, Jerusalem, Israel,
April 2-7, 1989. The permissive role of growth hormone in ovulation induction with human
menopausal gonadotropin.
16.
Annual meeting of the American Fertility Society, San-Francisco, CA. Early pregnancy factor
determination in pregnant and IVF/ET patients, and in human embryo cultures, 1989.
17.
The Second Congress of the International Society of Gynecological Endocrinology, Jerusalem, Israel Member of the scientific committee. The synergistic effect of growth hormone to gonadotropins in
achievement of conceptions in "Clonidine negative" patients with unexplained infertility- Invited
lecture, 1990.
18.
The VIIth Congress on Human Reproduction, Helsinki, Finland, June 26-July 1, 1990. Autoimmune
etiology to premature ovarian failure - incidence, induction of ovulation and pregnancies.
19.
The IInd International Symposium on IVF and Transvaginal Ultrasonography, Dubrovnik, Yugoslavia,
October 1-4, 1990. Transvaginal sonography in infertility and assisted reproduction. Ovulation
induction for IVF and assisted reproduction - Invited lectures.
20.
The IInd International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneve,
Switzerland, November 7-11, 1990. Treatment of uterine leiomyomata with GnRH analog (Nafarelin):
A clinical protocol of interrupted (on and off) treatment. Gonadotropin-releasing hormone analogues
for dysfunctional uterine bleeding in women after liver transplantation - a new application - Invited
lectures.
21.
International Conference on Advances in Ob/Gyn, Taipei, Taiwan, December 2-6, 1990 - Invited
Speaker. The role of GH in infertility.
22.
7th World Congress on IVF and Assisted Procreations, and 7th Annual Meeting of the European
Society of Human Reproduction and Embryology, Paris, France, June 28 - July 3, 1991. Growth
Hormone - Binding Protein (GH-BP) levels in follicular fluid from human preovulatory follicles:
Correlation with serum GH-BP levels. A possible "Carry over" effect of growth hormone in
restoration of fertility in "Clonidine negative" patients. Growth hormone - binding protein (GH-BP)
correlation with estrogen, progesterone, and gonadotropins in human: The effect of ovulation
induction with growth hormone, hMG, and gestation. Direct observation and evaluation of the in-vitro
effect of cigarette smoke on sperm motility using a specially designed mini-chamber.
23.
ESHRE Campus, Tel-Aviv, September 1991. The role of GH and GH-BP in ovarian physiology Invited lecture.
24.
Annual meeting of the Society of Gynecologic Investigation, San Antonio, TX, USA, March 18-21,
1992. Growth Hormone - Binding Protein (GH-BP) in human serum and follicular fluid: Correlation
with estrogen, progesterone, testosterone and gonadotropins. "Paradoxical cure" of 21-hydroxylase
late onset adrenal hyperplasia by cyproterone acetate. Early second trimester diagnosis of fetal
gallbladder anomalies by transvaginal sonography (TVS): Report of eleven cases.
25.
International Conference on Rheumatic Diseases in Pregnancy, Jerusalem, May 17-22. Doppler
studies of umbilical and uterine artery in patients with SLE treated with aspirin and corticosteroids
throughout pregnancy. Low molecular weight heparin (Clexan) in pregnancy in antiphospholipid
antibody syndrome, 1992.
26.
ARTA meeting, Costa Brava, Spain, August 17-20, 1992. Early pregnancy/ embryonic wastage: The
role of repetitive hCG supplementation during the first eight weeks of gestation. Transvaginal
23
.
ultrasonography to evaluate anomalies of early pregnancy. Spontaneous fetal reduction in multiple
gestations assessed by transvaginal ultrasonography. Growth factors - role of growth hormone Invited lectures.
27.
3rd International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva,
Switzerland, February 25-28, 1993. New clinical indications for GnRH-analogues: Menstrual asthma,
thalamic hemangioma, breast carcinoma, and lymphomas in young women - Invited lecture.
28.
3rd Pituitary Congress, Los Angeles, CA, June 13-15, 1993 - invited speaker. The role of GH in
ovulation induction.
29.
Ovarian Physiology and Ovulation Induction, Tel Aviv, July 28-30, 1993. Native GnRH for triggering
follicular maturation in PCO patients undergoing hMG ovulation induction. The role of GH in
ovulation induction,.
30.
8th Annual Meeting of the European Association of Gynecology and Obstetrics, Ljublijana, Slovenia,
October 13-16, 1993. Polycystic ovaries syndrome - from basic science to clinical practice - Invited
lecture.
31.
ESHRE Campus, Tel Aviv, Israel, November 9-11, 1993. Invited lecture - The need of luteal phase
supplementation in ovulation induction in vivo,.
32.
Symposium on Repeat Spontaneous Abortions ("La Variabile Immunologica Nelle Problematiche
Reproduttive"), Rome, Italy, March 12, 1994 (invited lecture). Treatment of repeat spontaneous
abortions with corticosteroids and low-dose aspirin: biophysical follow-up, therapy, and results,.
33.
41st Annual meeting of the Society for Gynecologic Investigation, Chicago, IL. March 22-26, 1994.
Growth hormone - binding protein (GH-BP) and IGF-I levels correlate with testosterone levels in
hypogonadotropic azoospermic men treated by intravenous pulsatile GnRH pump. Extensive
transvaginal sonographic (TVS) examination in the early second trimester for the detection of fetal
malformation.
34.
SAR Symposium on Assisted Reproduction, Bled, Slovenia, October 16-19, 1994. The Role of growth
factors, growth hormone (GH), its receptor and binding protein in ovarian physiology and ovulation
induction - new aspects to an old problem - Invited lecture,.
35.
The 2nd IGF Workshop-Invited Lecture. Beer-Sheba, Israel. Nov 21, 1994. The role of growth factors,
GH, its receptor and binding protein (GH-BP) in ovarian physiology,.
36.
42nd Annual meeting of the Society for Gynecologic Investigation, Chicago, IL. March 15-18, 1995.
Prevention of irreversible ovarian damage in young women with lymphoma by a gonadotropinreleasing hormone (GnRH) agonist in parallel to chemotherapy.
37.
Fourth International Conference on Systemic Lupus Erythematosus - SLE, Jerusalem, Israel, March
26-31, 1995. Systemic lupus erythematosus - the gynecologic connection: an overview.
38.
Annual Meeting of the Israeli Fertility Society, Tel-Aviv, April 30-May 2, 1995. Member of Scientific
and Organizing Committee. Follow up of fertility parameters after ligation of left spermatic vein in
cases of varicocoele and male infertility. Induction of spermatogenesis and fertility in
hypogonadotropic azoospermic men by IV pulsatile GnRH pump combined with ART in their
spouses. Pitfalls in the diagnosis of virilizing ovarian and adrenal andorgen secreting tumors by
selective venous catheterization and sampling.
39.
7th meeting - European Neuroendocrine Association. Jerusalem, October 21-25, 1995. The role of
GH, GH-BP, GH-RH and GH-receptor in reproduction and ovulation induction.
40.
4th International Symposium on GnRH-A in cancer and human reproduction, Geneve Feb. 8-11.
Prevention of irreversible ovarian damage by a GnRH-A in parallel to chemotherapy in young women
with lymphoma, 1996.
41.
Annual meeting of the Society for Gynecologic Investigation. Philadelphia USA, March 20-23, 1996.
Response of human fetal pituitary cells to Inhibin and Activin in-vitro.
42.
Annual meeting of the Society for Gynecologic Investigation. Philadelphia USA, March 20-23, 1996.
Culture of early somites state rat embryos in sera of women with spontaneous abortions of
autoimmune and unknown etiology results in a high rate of embryonic anomalies.
24
.
43.
Annual Meeting of the Society for Gynecologic Investigation, San Diego, California, March 20-22,
1997. Activin and Inhibin in human reproduction. Invited lecture. Inhibin-A concentrations in sera of
young women during and following chemotherapy for lymphoma - correlation with ovarian toxicity.
Inhibin-B concentrations increase whereas growth hormone binding protein (GH-BP) decrease in
hypogonadotropic hypogonadal (HH) men treated by pulsatile, intravenous GnRH-ART for fertility
achievement. The role of glucocorticosteroids cotreatment in conjunction with hMG/hCG
superovulation in hyperandrogenic, PCOS infertile patients. The origin of asictes in the ovarian
hyperstimulation syndrome is mainly ovarian in men.
44.
10th World Congress on IVF/ART, Vancouver, Canada, May 24-28, 1997. Comparison of in-vivo
fertilization to IVF in patients with at least one patent tube. Successful deliveries of three 46 XY
neonates born to a 46 XY father and ... 46 XY mother. The role of glucocorticosteroid cotreatment in
conjunction with hMG/hCG super ovulation in hyperandrogenic, PCOS infertile patients. . (Invited
speaker).
45.
International Congress on Fallopian Tubes, Bombay, India, February 6-8, 1998. IVF for Fallopian
Tube Disease-Use and Abuse.(Faculty and invited speaker), 1998.
46.
International FIVIER Symposium on OHSS, Valencia, Spain, Dec. 4-5, 1998. The Ovary as the Origin
of OHSS. and A Rationalized Treatment for OHSS. (Invited speaker).
47.
The 5th International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva,
Switzerland, Feb. 4-7, 1999. (Faculty and invited speaker),
48.
The 23rd Madhya Kerala Ob/Gyn Scientific Meeting, Cochin, Kerala, India. February 19-21 (Faculty
and invited speaker), 1999.
49.
50.
The 2nd International Congress on Autoimmunity, Tel Aviv, March 7-12, 1999. (Invited speaker).
51.
The 2nd International Symposium on Assisted Reproduction. Bled, Slovania October 10-13, 1999.
Preservation of ovarian function in young women treated by chemotherapy (Invited speaker).
52.
NIH workshop: “the Ovary: Genesis, function and failure”. Invited speaker:” Ovarian rescue/
protection from chemotheraputic agents. March 30-31, 2000, NICHD, Bethesda MD USA.
53.
International congress of reproductive medicine, Tel-Aviv, April 11-14, 2000. Chairman of scientific
sessions + speaker.
54.
4th world conference on early pregnancy, PECS, Hungary June 1-3 2000. Invited speaker and
chairman of session.
55.
International Conference “Human Fertility and Reproduction: The Oocyte, the Embryo and the
Uterus”. New-York, October 2-4 2000. Invited speaker.
56.
“Trends in Reproductive Medicine” Congress, Erlangen, Germany. October 12-14 2000. Invited
speaker and Chairman of scientific session.
57.
The 8th World Congress of Gynecological Endocrinology, Florence, Italy. December 6-9,2000.
Invited speaker and Chairman of scientific meeting.
58.
The 6th International symposium on GnRH Analogues in Cancer and Human Reproduction. Geneva ,
Feb 8-11 , 2001(invited speaker)
59.
XII International Workshop on the Development and Function of the Reproductive Organs: Advances
in Reproduction Research- from Follicle Culture to Nuclear Transfer and Embryonic Stem Cells.
Maale-Hachamisha, Israel, Apr 30th -May3rd, 2001. (Organizing Committee & Invited speaker)
60.
Turkish Gynecological Society National Meeting -Istanbul Turkey, Sept 13-16 2001. Invited speaker:
“PCOS- New treatments for an old problem”, “Preservation of ovarian function in young women
treated with chemotherapy.
61.
Fifth Internationl symposium on Hodgkin’s Lymphoma. Sept 22-25, 2001’ Koeln, Germany. Invited
speaker: Minimizing ovarian insufficiency-clinical and Investigational strategies.
62.
Adavances in Reproduction- Oct 6, 2001- Nicosia Cyprus. Invited Plenary Lecture.
The 46th annual meeting of SGI Atlanta, GA, March 10-13, 1999. Prevention of Ovarian Damage
during Chemotherapy. (Invited speaker).
25
.
63.
International congress of Endoscopy and human reproduction – Plenary Lecture, Dec 6-9 Goa IndiaFaculty and Invited speaker
64.
65.
49th annual meeting of the Society for Gynecologic Investigation. March 20-23, 2002. LA California.
66.
Seventh International Symposium on GnRH-analogues in Cancer and Human Reproduction.
Amsterdam, the Netherlands, February 6-9, 2003. Invited Speaker- Plenary Lecture.
67.
23rd Ann Meeting of the American Society for reproductive Immunology.Yale, New- Haven,
Connecticut.USA. June 18-22, 2003. Invited Speaker- Plenary Lecture.
68.
Parenthood after Cancer- an international symposium at the MD Anderson Cancer Center. March
4-7, 2004.Houston.TX. Invited speaker- Plenary Lecture.
The 51st annual meeting of the Society for Gynecologic Investigation [SGI]. Organizer and
moderator of Symposium on Preservation of Ovarian Function and Fertility in Survivors of
Chemotherapy- Plenary Lecture. Houston.TX. March 24-27, 2004.
Programm des Expert Meeting: GnRH-Agonisten und Ovarschutz: Ovarian Protection from
chemotherapeutic Agents with GnRH-Agonists. Vienna, Austria. 16.04.2004-Invited speakerPlenary Lecture.
Menopause Symposium. The rationale of minimizing premature ovarian failure in young women
exposed to chemotherapy by using GnRH-a. Barcelona, Spain. May 10th, 2004 -Invited speakerPlenary Lecture.
Invited speaker to a summer course organized by Rei Juan Carlos University, Madrid, Spain. July
25-30th, 2004.
Invited speaker by the Flemish Society of Obstetrics and Gynecology (VVOG) and of the Dept of
Obstetrics and Gynecology at Leuven University Hospital, Belgium, to postgraduate study day on
"Infertility and Oncology" organized for gynecologists and oncologists on: "Role of LHRH
analogues in the prevention of infertility caused by chemotherapy" on Thursday October 28th
2004.
Invited speaker - Asian Pacific Congress on Controversies in Obstetrics, Gynecology and
Infertility-. Preservation of fertility in-spite of chemotherapy in women-Present practice and future
endeavours / hopes- Plenary Lecture. Bangkok, Thailand, November 25-29, 2004.
Invited speaker - Asian Pacific Congress on Controversies in Obstetrics, Gynecology and
Infertility Hormonal suppressive therapy of endometriosis - are we really improving the patient's
health. Plenary Lecture. Bangkok, Thailand, November 25-29, 2004.
Invited speaker – Gynecologic Surgery. March 9-11, 2005, Barcelona.
Invited speaker – “Oncology Overall Symposium”. Meuhedet Med Services; Haifa, 2005.
Invited speaker – GIF Endocrinology. An emerging, growing scientific discipline and its future
prospects for medical applications. February 12-16, 2006 Dead Sea, Israel.
Blumenfeld Zeev, Invited speaker – “Gonadal protection by previous administration of GnRH
analogues” in: “Ovarian Failure. From conception to menopause ” -European Society of
Gynecology Meeting, Hospital de la Santa Creu i Sant Pau – Barcelona, May 26- 27, 2006.
Blumenfeld Zeev, Invited speaker –“Gender Medicine- The role of GnRH-a in preventing
premature ovarian failure in young women but not in men exposed to gonadotoxic
chemotherapy”-Second international Gender Medicine Congress. Rome, Italy, March 8-11,2007.
Blumenfeld Zeev, Invited speaker –“Debate- The role of medical treatment for fertility
preservation”-Annual meeting of the Society for gynecologic Investigation. Reno, Nevada, USA,
March 14-18, 2007.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
International symposium on preservation of fertility in autoimmune/rheumatic diseases treated by
chemotherapy- Alexander University, Erlangen, Germany. May 16, 2002. Invited speaker.
26
.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”International Symposium on Cancer and Reproduction. Valencia, Spain, March 25-27, 2007.
Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”ESHRE workshop on Cancer and Reproduction. Brussels, Belgium, April 13-14, 2007.
Invited speaker –“The role of medical/surgical treatment for a malignant transformation of
endometriosis” – Z. Blumenfeld-ESHRE- Ann Meeting, Lyon, France, July 1-4, 2007.
Blumenfeld Zeev, Invited speaker –“Fertility Preservation despite Chemotherapy- the Role of
GnRH-a, Cryopreservation of Embrya, Oocytes, or Ovaries”- 9th GnRH-a Symposium on
Cancer & Reproduction. Berlin, Germany, February 9-10, 2008.
Blumenfeld Z, Invited speaker-”. The 13th Congress of the European Hematology Association.–
“The role of medical treatment for fertility preservation". Copenhagen, Denmark, June 13-16, 2008.
Blumenfeld Z, Invited speaker-Symposium of A-PART –“Fertility preservation in young women
exposed to chemotherapy. The role of GnRH analogues cotreatment in addition to cryopreservation of
embrya, oocytes, or ovarian tissue". Tokyo, Japan, July 20-21, 2008.
Blumenfeld Zeev, Invited speaker-ESHRE Campus on Fertility preservation in severe diseases –
“Fertility preservation in young women exposed to chemotherapy. The role of GnRH analogues
cotreatment". Heidelberg, Germany, November 14-15, 2008.
Blumenfeld Zeev, Invited speaker-ESHRE ann meeting, –“Fertility preservation in young women
exposed to chemotherapy. The role of GnRH analogues". Rome, Italy, June 27-30, 2010.
Blumenfeld Zeev, Invited speaker-WARM [World Association Reproductive Medicine]–1." Growth
factors in folliculogenesis and IVM", & 2. “Fertility preservation in women exposed to chemotherapy.
The role of GnRH analogues". Moscow, Russia, October 10-13, 2010.
Blumenfeld Zeev, Invited speaker-ESHRE Campus on Fertility preservation in severe diseases –
“Fertility preservation in young women exposed to chemotherapy. The role of GnRH analogues".
Bologna, Italy, November 25-27, 2010.
Blumenfeld Zeev, Invited speaker-ESHRE Campus on Cancer and Fertility. Kempten, Germany,
February 4, 2011.
Blumenfeld Zeev, Invited speaker-GnRH Congress in Cancer and Human Reproduction. Salzburg,
Austria. February 6-8, 2011.
Blumenfeld Z, Invited speaker and chairman of scientific session. Thirty Years of Advances in
Reproductive Endocrinology & ART: A Celebration Congress, Montreal, Canada, May 27-31, 2011.
Blumenfeld Z, Invited speaker and chairman of scientific session. "Innovations and competence in
current medical practice". [Four invited lectures: 1.Fertility preservation; 2.PCOS-state of the art;
3.Inhibin, Activin, AMH and TGF superfamily, 4.Familial breast and ovarian cancer. Samara,
Russia, Nov 24-26, 2011.
Blumenfeld Z, Invited speaker. "An ounce of prevention is worth a pound of cure"- The case for and
against GnRH-agonist for fertility preservation." Target Meeting- 2nd World Cancer Online
Conference. January 8-11, 2013
Blumenfeld Z, Invited speaker- Ovarian cryopreservation and fertility preservation congress
[OPFP], Berlin, 20-22.3.2013.
Blumenfeld Z, Invited speaker. "Fertility show congress". [Three invited lectures: 1.Fertility
preservation; 2.PCOS-state of the art; 3.Inhibin, Activin, AMH and TGF superfamily. Moscow,
Russia, April 13-14, 2013.
Blumenfeld Z, Member of scientific committee, chairman of fertility preservation session,
moderator of session on Stem Cells. Society for gynecologic investigation summit, Jerusalem,
June 28-30, 2013.
Ovarian Club meeting, Paris, November 2013, (invited speaker)
27
.
101.
The 11th International symposium on GnRH Analogues in Cancer and Human Reproduction.
Salzburg, Feb 9-12, 2014 (invited speaker-."An ounce of prevention is worth a pound of cure")
102.
103.
Annual meeting of the Society for gynecologic Investigation. Florence, Italy, March 26-29, 2014.
2nd World Congress on Ovulation Induction & Ovarian Stimulation Protocols-WOOSP2014,
Jaipur, India, August 7-10,2014. (Faculty and invited speaker).
INVITED LECTURES AND CHAIRMAN OF MEETINGS
International:
1. Chairman of the Sessions on Neuroendocrinology and Reproduction, the Second Congress of the International
Society of Gynecological Endocrinology, Jerusalem, 1990.
2. Chairman of the scientific session on GnRH analogues usage in treatment of uterine leiomyomata - IInd
International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, 1990.
3. Invited speaker in the IInd Symposium on IVF and Transvaginal Ultrasonography, Dubrovnik, Yugoslavia,
1990.
4. Invited lectures in Taipei, Taiwan (Advances in Obstetrics and Gynecology, December 1990), Seoul, Korea,
and Singapore (1990).
5. Invited lecture and member of faculty in ESHRE Campus Workshop, September 3-5, 1991, Tel Aviv, Israel.
6. Invited lectures - Assisted Reproductive Technology meeting, Costa Brava, Spain, August 1992.
7. Invited lecture on "Infertility, Stress and Growth Hormone - Binding Protein", 14th World Congress of
International Federation of Fertility Societies (IFFS), Caracas, Venezuela, November 1992.
8. Invited lecture, and chairman of the scientific session on "GnRH agonists in various gynecological situations"
at the 3rd International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva,
Switzerland, February 25-28, 1993.
9. Invited lecture: "The Role of Growth Hormone in Ovulation Induction", the 3rd International Pituitary
Congress, Los-Angeles, CA, June 13-15, 1993.
10. Invited lecture: "The Role of Growth Hormone, Growth Factors, and GH-BP in Reproductive Endocrinology",
Sao Paulo, Brazil, August, 1993.
11. Invited lecture: "PCO - From Basic Science to Daily Practice", 8th Congress of the European Association of
Gynecologists and Obstetricians, Ljubliana, Slovenia, October 13-15, 1993.
12. Invited lecture:"The Corpus Luteum", ESHRE Campus, Tel Aviv, November 1993.
13. Invited lecture: "Treatment of spontaneous abortions with corticoids and low-dose aspirin - biophysical
follow-up, therapy, & results". Symposium on repeat spontaneous abortions, Rome, Italy, March 12-13,1994.
14. Invited lecture and chairman of scientific session, 4th International Symposium on GnRH-A in Cancer and
Human Reproduction, Geneve, February 1996.
15. Invited lecture: "Activin and Inhibin: Applications in Human Research and Possible Clinical Extrapolations".
The 44th Annual Meeting of the Society for Gynecologic Investigation (SGI), San Diego, CA (USA), March
19-22, 1997.
16. Chairman of scientific sessions at the 10th world congress of IVF and Assisted Reproduction, Vancouver,
Canada, May 24-28, 1997.
17. Invited lecture: "Inhibin and Activin in Human Research and Future Endeavors" - Northwestern University
Endocrine Research Meeting, May 29, 1997.
18. Invited lecture and International Faculty: "IVF for Fallopian Tube Disease - Use and Abuse". International
congress on Fallopian tubes, Bombay, India, February 6-8, 1998.
19. Invited lectures: "The ovary as the origin of OHSS", and "A rationalized treatment for OHSS". FIVIER
symposium on OHSS, Valencia, Spain, December 4-5, 1998.
20. Invited lecture: "Preservation of ovarian function in young women undergoing chemotherapy. 5th
International symposium on GnRH analogues in cancer and human reproduction. Geneva Switzerland, Feb. 47, 1999.
28
.
21. Invited lecture and International Faculty: "Inhibin and Activin" and "OHSS - State of the ART" - Madhya
Kerala Ob/Gyn meeting, Cochin, Kerala, India, Feb. 19-21, 1999.
22. Invited lecture: "Repeated pregnancy wastage associated with Thrombophilia and APLS - Immunologic,
Hematologic, and Embryotoxic factors" - 2nd International Congress on Autoimmunity, Tel-Aviv, March 7-12
1999.
23. Chairman of scientific session and organizing committee – “Progesterone, Progestins and Antiprogestins in
the Next Millenium, Jerusalem 1-3, 1999.
24. Invited lecture: "Prevention of Ovarian Damage during Chemotherapy/ Prevention of POF" - Society for
Gynecologic Investigation (SGI), 46th annual meeting, Atlanta, GA (USA), March 10-13, 1999.
25. Invited lecture: The 2nd International Symposium on Assisted Reproduction. Bled, Slovania October 10-13,
1999. Preservation of ovarian function in young women treated by chemotherapy (Invited speaker and
Chairman of Scientific Session).
26. NIH workshop: “the Ovary: Genesis, function and failure”. Invited speaker:” Ovarian rescue/ protection from
chemotheraputic agents. March 30-31,,2000NICHD, Bethesda MD USA.
27. International congress of reproductive medicine, Tel-Aviv, April 11-14 2000.Chairman of scietific sessions +
speaker.
28. 4th world conference on early pregnancy, PECS, Hungary June 1-3 2000. Invited speaker and chairman of
session.
29. “Human Fertility and reproduction: the Oocyte, the embryo and the uterus” Oct. 2-4,2000, NYU New York
USA.
30. “International workshop: ART in Y2K. Oct 5-8, 2000 Goa, India. International scientific commettee and
invited lecturer.
31. “XI International symposium on Ultrasound in Perinatology & Gynecology”, Buenos Aires, Argentina, Nov
23-25 2000.
32. “8th World congress on Gynecological Endocrinology, Florence, Italy Dec 6-9 2000.
33. The 6th International symposium on GnRH Analogues in Cancer and Human Reproduction. Geneva, Feb 811, 2001(invited speaker)
34. XII International Workshop on the Development and Function of the Reproductive Organs: Advances in
Reproduction Research- from Follicle Culture to Nuclear Transfer and Embryonic Stem Cells. MaaleHachamisha, Israel, Apr 30th -May3rd, 2001. (Organizing Committee & Invited speaker)
35. Turkish Gynecological Society National Meeting -Istanbul Turkey, Sept 13-16 2001. Invited speaker: “PCOSNew treatments for an old problem”, “Preservation of ovarian function in young women treated with
chemotherapy.
36. Fifth Internationl symposium on Hodgkin’s Lymphoma. Sept 22-25,2001’ Koeln, Germany. Invited speaker:
Minimizing ovarian insufficiency-clinical and Investigational strategies.
37. Adavances in Reproduction- Oct 6, 2001- Nicosia Cyprus. Invited Lecture.
38. Internation congress of Endoscopy and human reproduction – Dec 6-9 ,2001. Goa India- Faculty and Invited
speaker.
39. International symposium on preservation of fertility in autoimmune/rheumatic diseases treated by
chemotherapy- Alexander University, Erlangen, Germany. May 16, 2002. Invited speaker.
40. The 7th International symposium on GnRH Analogues in Cancer and Human Reproduction, Amsterdam, The
Netherlands, Feb 6-9, 2003(invited speaker).
41. 23rd Ann Meeting of the American Society for reproductive Immunology.Yale, New- Haven,
Connecticut.USA. June 18-22, 2003. Invited Speaker.
42. Fertility after Cancer.MD Anderson Cancer Center meeting. Houston, March 4th-7th, 2004. Invited Speaker.
43. Organizer and Moderator of an SGI symposium on Preservation of Fertility in spite of gonadotoxic
chemotherapy. Ann meeting of the Society forGynecologic Investigation, Houston, TX, March 24 th-28th, 2004.
29
.
44. Programm des Expert Meeting: GnRH-Agonisten und Ovarschutz: Ovarian Protection from
chemotherapeutic Agents with GnRH-Agonists. Vienna, 16.04.2004-Invited speaker.
45. Menopause Symposium. The rationale of minimizing premature ovarian failure in young women exposed
to chemotherapy by using GnRH-a. Barcelona, Spain. May 10th, 2004 -Invited speaker.
46. Invited speaker to a summer course organized by Rei Juan Carlos University, Madrid, Spain. July 25-30th,
2004.
47. Invited speaker by the Flemish Society of Obstetrics and Gynecology (VVOG) and of the Dept of
Obstetrics and Gynecology at Leuven University Hospital, Belgium, to postgraduate study day on
"Infertility and Oncology" organized for gynecologists and oncologists on: "Role of LHRH analogues in
the prevention of infertility caused by chemotherapy" on Thursday October 28th 2004.
48. Invited speaker and Chairman of Scientific session- Asian Pacific Congress on Controversies in
Obstetrics, Gynecology and Infertility Plenary Lectures. Bangkok, Thailand, Nov. 25-29, 2004.
49. Invited speaker – GIF Endocrinology An emerging, growing scientific discipline and its future prospects
for medical applications.February 12-16, 2006 Dead Sea, Israel.
50. Invited speaker – “Gonadal protection by previous administration of GnRH analogues” in: “Ovarian
Failure. From conception to menopause” -European Society of Gynecology Meeting, Hospital de la Santa
Creu i Sant Pau – Barcelona, May 26- 27, 2006.
51. Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”- Serono
Symposia International Foundation Conference on: Reproduction and Malignant Disease. Barcelona,
Spain - September 15-16, 2006.
52. Blumenfeld Zeev, Invited speaker –“The role of GnRH-a and medical treatment for fertility
preservation”- Reproduktionsmedizin Und Endokrinologie – Innsbruch and Linz. Austria. October 24-28,
2006.
53. Blumenfeld Zeev, Invited speaker -The 2nd World Congress on Gender-Specific Medicine and Aging:
THE ENDOCRINE IMPACT. Rome, Italy, March 8-11, 2007.
54. Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”-The annual
meeting of the Society for Gynecologic Investigation [SGI]. Reno, Nevada,USA, March 14-18, 2007.8-
11 • 200March 8-11 • 2
55. Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”-International
Symposium on Cancer and Reproduction. Valencia, Spain, March 25-27, 2007.
56. Invited speaker –“The role of medical/surgical treatment for a malignant transformation of endometriosis
– Z. Blumenfeld”-ESHRE- Ann Meeting, Lyon, France, July 1-4, 2007.
57. Blumenfeld Zeev, Invited speaker –“Fertility Preservation despite Chemotherapy- the Role of GnRH-a,
Cryopreservation of Embrya, Oocytes, or Ovaries”- 9th GnRH-a Symposium on Cancer &
Reproduction. Berlin, Germany, February 9-10, 2008.
58. Blumenfeld Zeev, Invited speaker-”. The 13th Congress of the European Hematology Association.–“The
role of medical treatment for fertility preservation". Copenhagen, Denmark, June 13-16, 2008.
59. Blumenfeld Zeev, Invited speaker-Symposium of A-PART –“Fertility preservation in young women exposed
to chemotherapy. The role of GnRH analogues cotreatment in addition to cryopreservation of embrya,
oocytes, or ovarian tissue". Tokyo, Japan, July 20-21, 2008.
60. Blumenfeld Zeev, Invited speaker-ESHRE Campus on Fertility preservation in severe diseases –“Fertility
preservation in young women exposed to chemotherapy. The role of GnRH analogues cotreatment".
Heidelberg, Germany, November 14-15, 2008.
61. Blumenfeld Zeev, Invited speaker-ESHRE annual meeting, pre-congress course –“Fertility preservation in
young women exposed to chemotherapy. The role of GnRH analogues". Rome, Italy, June 27-30, 2010.
30
.
62. Blumenfeld Zeev, Invited speaker-WARM [World Association Reproductive Medicine]–1." Growth factors in
folliculogenesis and IVM", & 2. “Fertility preservation in women exposed to chemotherapy. The role of
GnRH analogues". Moscow, Russia, October 10-13, 2010.
63. Blumenfeld Zeev, Invited speaker-ESHRE Campus on Fertility preservation in severe diseases –“Fertility
preservation in young women exposed to chemotherapy. The role of GnRH analogues". Bologna, Italy,
November 25-26, 2010.
64. Blumenfeld Zeev, Invited speaker-ESHRE Campus on Cancer and Fertility. Kempten, Germany, February 4,
2011.
65. Blumenfeld Zeev, Invited speaker-GnRH Congress in Cancer and Human Reproduction. Salzburg, Austria.
February 6-8, 2011.
66. Blumenfeld Z, Invited speaker and chairman of scientific session. Thirty Years of Advances in Reproductive
Endocrinology and ART: A Celebratory Congress, Montreal, Canada, May 27-31, 2011.
67. Blumenfeld Z, Invited speaker and chairman of scientific session. "Innovations and competence in current
medical practice". [Four invited lectures: 1.Fertility preservation; 2.PCOS-state of the art; 3.Inhibin, Activin,
AMH and TGF superfamily, 4.Familial breast and ovarian cancer. Samara, Russia, Nov 24-26, 2011.
68. Blumenfeld Z, Invited speaker." An ounce of prevention is worth a pound of cure"-The case for and against
GnRH-agonist for fertility preservation." Target Meeting- 2nd World Cancer Online Conference .January 811, 2013
69. Blumenfeld Z, Invited speaker- Ovarian cryopreservation and fertility preservation congress [OPFP],
Berlin, 20-22.3.2013.
70. Blumenfeld Z, Invited speaker. "Fertility show congress". [Three invited lectures: 1.Fertility preservation;
2.PCOS-state of the art; 3.Inhibin, Activin, AMH and TGF superfamily. Moscow, Russia, April 13-14, 2013.
71. Blumenfeld Z, Member of scientific committee, chairman of fertility preservation session, moderator of
session on Stem Cells. Society for gynecologic investigation summit, Jerusalem, June 28-30,2013.
72. Ovarian Club meeting, Paris, November 2013, (invited speaker)
73. The 11th International symposium on GnRH Analogues in Cancer and Human Reproduction. Salzburg, Feb 912, 2014 (invited speaker-."An ounce of prevention is worth a pound of cure")
74. 2nd World Congress on Ovulation Induction & Ovarian Stimulation Protocols-WOOSP2014, Jaipur,
India, August 7-10,2014. (Faculty and invited speaker).
National:
1. Chairman of the scientific session on IVF - Annual meeting of the Israel Endocrine Society, Jerusalem, 1986.
2. Chairman of the scientific sessions - Annual meetings of the Israeli Society for Fertility Research, 1987-1997.
3. Chairman of the scientific meeting on Reproductive Endocrinology - The Annual Meeting of the Israel
Endocrine Society, Jerusalem, 1989-1997.
4. Member of the scientific committee of the annual meeting, The Israeli Society for Fertility Research, 1990.
5. Elected as member of the directory council of the Israel Fertility Association, 1991.
6. Chairman of scientific sessions of the annual meeting of the Israeli Fertility Society, 1992, 1993.
7. Member of the scientific council of: "Ovarian Physiology and Ovulation Induction", Tel Aviv, July 1993.
8. Chairman of the scientific sessions and member of the organizing committee of the Annual Meeting of the
Israeli Fertility Society, Tel Aviv, April-May 1995.
9. Chairman of scientific session: The International Symposium on “New Trends in Menopausal Care”.
Jerusalem’ March 15-16 1998.
10. Chairman of scientific sessions, member of faculty - scientific committee, and invited lecturer" "Inhibin and
Activin - Future Endeavors". The National Meeting of the Israeli Society of Obstetrics and Gynecology,
Haifa, January 13-14, 1999.
31
.
11. Chairman of neuroendocrine session - The Annual Meeting of the Israel Endocrine Society, Tel-Aviv, January
25-26, 1999.
12. Chairman of the scientific session and invited lecturer: PCOS – Clinical Debate- the Annual Meeting of the
Israel Endocrine Society, Tel Aviv, November 2-3, 1999.
13. The annual meeting of the Israel Endocrine Society 2000 Tel Aviv-Chairman of Scientific Session..
14. The annual meeting of the Israel Endocrine Society Jan 23-24, 2001 Tel Aviv-Chairman of poster prize
session.
15. Advances in reproduction- Invited Speaker Dec 19 2000, Hebrew Univ. Symposium Beith Dagan.
16. The ann. Meeting of the Israel Fertility Society-Prize committee member. May 15-16th 2003.Tel-Aviv.
17. Fertility Preservation despite Gonadotoxic Chemotherapy. -Invited lecture-The annual Meeting of the Israel
Society of Hematology. July 1st, 2003.Tel-Aviv.
18. Annual Meeting of the Israel Endocrine Society, Chairman of Session on Reproduction, Dec10-11th, 2003.
Tel-Aviv.
19. Member of scientific/organizing committee “Meuhedeth 100” convention, Chairman of session on
reproduction. Haifa, Jan.21st, 2004.
20. Fertility Preservation despite Gonadotoxic Chemotherapy. -Invited lecture-Liss Maternity Hospital Ob.Gyn.
Meeting. Tel-Aviv. June 6, 2004.
21. Blumenfeld Z. Invited speaker: RAMBAM staff meeting conference. March 9th, 2006. ‫הירסוטיזם – קצה‬
‫הקרחון של תסמונת השחלות הפוליציסטיות – אבחנה וטיפול‬
22. Blumenfeld Z. Ann. Meeting-Israel Endocrine Society [IES] Chairman-Neuroendocrinology Session.4.2008,
Tel-Aviv.
23. Blumenfeld Z. Annual meeting of the Israel Fertility Association- 5.2008, Tel-Aviv.
24. Blumenfeld Z. Ann. Meeting-the Israel Endocrine Society [IES] 3.2009, Tel-Aviv. Organizing Committee.
25. Blumenfeld Z. 19th Israeli Med. Assoc. World Fellowship Internat.Conf, Tel Aviv, April 22 - 26, 2009.
26. Blumenfeld Z. Annual meeting of the Israel Fertility Association, Tel-Aviv, May11-12, 2009.
27. Blumenfeld Z. Meuhedet meeting-Obesity. Haifa. May 20th, 2009.
28. Blumenfeld Z. Israel Fertility Association meeting. [Yearoth-Hacarmel]- June 4-6, 2009.
29. Blumenfeld Z. Gynecology in Adolescents Society. Chairman of PCOS session [Tel-Aviv] - November 11th,
2009.
30. Blumenfeld Z. The 39th annual meeting of the Israeli Endocrine Society (IES). Tel-Aviv, April 13-14, 2010.
Chairman of session and organizing committee.
31. Blumenfeld Z. Ann meeting, the Israel Fertility Association, Tel-Aviv, May10-11, 2010. Session Chairman.
32. Blumenfeld Z. Ob.Gyn. Society. Organizer, Chairman, and Speaker - session on fertility preservation [TelAviv] - July 30th, 2010.
33. Blumenfeld Z. The 40th annual meeting of the Israeli Endocrine Society (IES). Nazareth, April 5-7, 2011.
Chairman of session and organizing committee.
34. Blumenfeld Z. Ann meeting, the Israel Fertility Association, Tel-Aviv, May16-17, 2011. Session Chairman.
35. Blumenfeld Z. Meuhedet meeting-Innovations. Haifa. March 14th, 2012.
36. Blumenfeld Z. The 41st annual meeting of the Israeli Endocrine Society (IES). Ramath-Gan, March 27-28,
2012. Chairman of sessions and member of organizing committee.
37. Blumenfeld Z. The 42nd annual meeting of the Israeli Endocrine Society (IES). Ramath-Gan, April 9-10,
2013. Chairman of reproductive endocrinology session.
38. Blumenfeld Z, Member of scientific committee, invited lecture, chairman of Ob-Gyn session, moderator
of sesions. Meuhedet meeting, Haifa, May 8, 2013.
32
.
39. Blumenfeld Z. The 43nd annual meeting of the Israeli Endocrine Society (IES). Tel-Aviv, April 9-8, 2014.
Chairman of reproductive endocrinology session. Oral presentation.
40. Blumenfeld Z. Ann meeting, the Israel Fertility Association, Tel-Aviv, May26-27, 2011. 2 abstracts presented.
41.
ABSTRACTS
1. Blumenfeld Z, Naor N, Merzbach D, Timor-Tritsch IE, Brandes JM: Incidence of group B streptococci
colonization in parturient women and infection in their neonates. Presented at the 7th Scientific Meeting of the
Israel Society of Obstetrics and Gynecology, Jerusalem, May 14-16, 1980.
2. Timor-Tritsch IE, Blumenfeld Z, Brandes JM, Zimmer E: Rapid estimation of fetal weight by real time
sonography. Presented at the 7th Scientific Meeting of the Israel Society of Obstetrics and Gynecology,
Jerusalem, May 14-16, 1980.
3. Blumenfeld Z, Beck D, Levithan E, Eshkol A, Brandes JM: An improved method of computerized serologic
monitoring of alpha fetoprotein half life time in treatment of endodermal sinus tumor of ovary. Presented at
the 7th Scientific Meeting of the Israel Society of Obstetrics and Gynecology, Jerusalem,
May 14-16,
1980.
4. Blumenfeld Z, Makler A, David R, Better OS: Sperm viability as affected by change of pH and osmolarity of
semen and urine specimens. Presented at the IInd International Congress of Andrology, Tel Aviv, June 1981.
5. Blumenfeld Z, Makler A, Hoch Z: The relationship between libido and blood testosterone levels. Presented at
Vth World Congress of Sexology, Jerusalem, June 1981.
6. Makler A, Blumenfeld Z, Leventhal D, Tamir A: Followup of various treatments of infertile men by objective
evaluation of sperm quality. Presented at the International Congress of Andrology, Tel Aviv, June 1981.
7. Blumenfeld Z, Ullman Y, Timor-Tritsch IE, Brandes JM: Systemic lupus erythematosus and pregnancy.
Presented at "An Update in High Risk Obstetrics" Organized by the Israel Society of Obstetrics and
Gynecology, and the University of Southern California School of Medicine, Post Graduate Division, Tel Aviv
and Jerusalem, November 18-23, 1981.
8. Blumenfeld Z, Lightman A, Deutsch M, Timor-Tritsch IE: Quick estimation of fetal weight by real time
ultrasonography - Evaluation of the technique by "Multiple Unskilled Users". Presented at "An Update in
High Risk Obstetrics" organized by the Israel Society of Obstetrics and Gynecology, and the University of
Southern California School of Medicine, Post Graduate Division, Tel Aviv and Jerusalem, November 18-23,
1981.
9. Blumenfeld Z, Deutsch M, Lightman A, Timor-Tritsch IE: Postdate pregnancies - suggested scheme of
management based on outcome analysis of 105 consecutive post-term gestations. Presented at "An Update in
High Risk Obstetrics" organized by the Israel Society of Obstetrics and Gynecology, and the University of
Southern California School of Medicine, Post Graduate Division, Tel Aviv and Jerusalem, November 18-23,
1981.
10. Blumenfeld Z, Aviram M, Brook JG, Brandes JM: Concentration and composition of lipoproteins in cord
blood. Presented at "An Update in High Risk Obstetrics" organized by the Israel Society of Obstetrics and
Gynecology and the University of Southern California School of Medicine, Post Graduate Division, Tel Aviv
and Jerusalem, November 18-23, 1981.
11. Makler A, Jakobi P, Deutsch M, Blumenfeld Z: Homologous intra-uterine insemination with sperm
resuspended in umbilical cord serum. Presented at the International Congress of Andrology, Tel-Aviv, 1981.
12. Blumenfeld Z, Beck D, Lightman A, Deutsch M, Brandes JM: The importance of markers in sera of women
with gynecologic tumors. Presented at the 1st National Conference on Gynecologic Oncology, Tel Aviv,
November 25-26, 1982.
13. Deutsch M, Beck D, Blumenfeld Z: Hyperalimentation in patients with gynecologic tumors. Presented at the
1st National Conference on Gynecologic Oncology, Tel Aviv, November 25-26, 1982.
33
.
14. Deutsch M, Beck D, Blumenfeld Z: The therapeutic mode in recurrence of granulosa cell tumor of the ovaries.
Presented at the 1st National Conference on Gynecologic Oncology, Tel Aviv, November 25-26, 1982.
15. Blumenfeld Z, Brandes JM, Israeli E, Beck D: Estrogen and progesterone receptors in breast and endometrial
cancer. Presented at the 12th World Congress of the Israel Medical Association, Jerusalem, May 25, 1982.
Presented at the IInd International Congress on Hormones and Cancer, Monte-Carlo, September 18-23, 1983.
16. Blumenfeld Z, Makler A, Gershon H, Brandes JM: An improved sperm immobilization test based on multiple
exposure photography. Presented at the Annual Meeting of the American Fertility Society, New Orleans, 1984
and Am J Reprod Immunol and Microbiol 1985; 7:27.
17. Monroe S, Blumenfeld Z, Schriock E, Andreyko J, Henzl M, Jaffe RB: Consideration in developing a
clinically useful GnRH agonist for contraception. Presented at the Annual Meeting of the Society for
Gynecologic Investigation, Phoenix, AZ, Abstract #47, 1985.
18. Andreyko J, Monroe S, Blumenfeld Z, Jaffe RB: Treatment of hirsutism with a GnRH agonist. Presented at
the Annual Meeting of the Society for Gynecologic Investigation, Phoenix, AZ, Abstract #73, 1985.
19. Blumenfeld Z, Martin M, Monroe S, Andreyko J, Dandekar P, Glass R: Comparison of the incidence of
premature ovulation with different stimulation protocols in an IVF program. Presented at the 41st Annual
Meeting of the American Fertility Society, Chicago, IL., Abstract #96, 1985.
20. Blumenfeld Z, Martin M, Goldsmith P, Jaffe RB: CRF can stimulate ACTH secretion in human fetal pituitary
glands during the first half of pregnancy. Presented at the Annual Meeting of the Society for Gynecologic
Investigation, Phoenix, AZ, Abstract #147, 1985.
21. Blumenfeld Z, Goldsmith PC, Jaffe RB: Modulation of human fetal pituitary ACTH by CRF, AVP, cAMP,
corticoids and catecholamines. Presented at the Annual Meeting of the Endocrine Society, Baltimore, MD,
Abstract #350, 1985.
22. Blumenfeld Z, Martin M, Monroe S, Dandekar P, Glass R: Late follicular LH patterns predict preovulatory
LH surge in ovulation induction. Presented at the Annual Meeting of the Society for Gynecologic
Investigation, Phoenix, AZ, Abstract #430, 1985.
23. Blumenfeld Z, Naoth Y, Gershon H, Makler A, Stoler J, Brandes JM: Detection of antisperm antibodies - a
cytotoxicity immobilization test. Presented at the IVth Franco-Israeli Colloqvium of Gynecology and
Obstetrics, Jerusalem, Israel (1985), p. 50.
24. Blumenfeld Z, Martin M, Monroe S, Andreyko J, Drugan A, Glass RH, Brandes JM: The predictive value of
LH values for premature LH surge in an IVF program. Presented at the IVth Franco-Israeli Colloqvium of
Gynecology and Obstetrics, Jerusalem, Israel (1985), p. 56.
25. Blumenfeld Z, Monroe S, Andreyko J, Henzl M, Jaffe RB: GnRH agonist (Nafarelin) for ovulation
suppression - clinical consideration and side effects. Presented at the IVth Franco-Israeli Colloqvium of
Gynecology and Obstetrics, Jerusalem, Israel, 1985, p. 62.
26. Blumenfeld Z, Ullman Y, Timor-Tritsch IE: Systemic Lupus Erythematosus (SLE) and Pregnancy: The
reciprocal effect between the disease and gestation. Presented at the IVth Franco-Israeli Colloqvium of
Gynecology and Obstetrics, Jerusalem, Israel, 1985, p. 64.
27. Blumenfeld Z, Schroick E, Monroe S, Andreyko J, Martin M, Jaffe RB: Induction of ovulation and conception
with pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea and polycystic ovarian disease
(PCOD). Proceedings of the Annual Meeting of the Israeli Endocrine Society. Herzliya (1985). Israel J Med
Sciences 1986; 22:502.
28. Blumenfeld Z, Jaffe RB: Hypophysiotropic and neuromodulatory regulation of ACTH in the human fetal
pituitary gland. Proceedings of the Annual Meeting of the Israel Endocrine Society, Herzliya (1985). Israel J
Med Sciences 1986; 22:497.
29. Blumenfeld Z, Tapaneinen P, Kaplan SL, Grumbach MM, Jaffe RB: Chronic exposure of cultured human fetal
pituitary cells to GRF causes partial loss of responsiveness to GRF. Presented at the 33rd Annual Meeting of
the Society for Gynecological Investigation, Toronto, Canada, Abstract #76, 1986.
30. Andreyko J, Blumenfeld Z, Marshall L, Hricak H, Cann C, Monroe S: Treatment of uterine leiomyomata with
a GnRH agonist. Presented at the 33rd Annual Meeting of the Society for Gynecological Investigation,
Toronto, Canada, 1986, Abstract #127.
34
.
31. Blumenfeld Z, Thaler I, Timor-Tritsch IE: Sonographic anatomy and embryology of the early pregnancy.
Presented at the IVth International Symposium on Ultrasound in Israel, 1986.
32. Blumenfeld Z, Drugan A, Erlik Y, Nahhas F, Segal E, Timor-Tritsch IE, Brandes JM: Monozygotic twins
after embryo transfer of a single embryo in an IVF program. Presented at the Annual Meeting of the Israeli
Society for Fertility Research, Weitzman Institute, Israel, 1986, p. 45.
33. Brandes JM, Drugan A, Itzkowitz I, Erlik Y, Nahhas F, Bar-Ami S, Blumenfeld Z: The "Unfertilized Ova
Syndrome" - A possible cause for unexplained infertility and failure of In-Vitro Fertilization. Presented at the
Annual Meeting of the Israeli Society for Fertility Research, Weitzman Institute, Israel, 1986, p. 38.
34. Drugan A, Bar-Ami S, Itskowitz I, Blumenfeld Z, Nahhas F, Brandes JM:
In vitro steroids secretion by
cumulus cells from an IVF-ET program. Presented at the Annual Meeting of the Israeli Society for Fertility
Research, Weitzman Institute, Israel, 1986, p. 60.
35. Nahhas F, Erlik Y, Blumenfeld Z, Drugan A, Segal E, Brandes JM: Correlation between the hamster test and
human ova In-Vitro Fertilization. Presented at the Annual Meeting of the Israeli Society for Fertility Research,
Weitzman Institute, Israel, 1986, p. 27.
36. Makler A, Blumenfeld Z, Brightman S, De-Cherney AH: A new device for intra-uterine insemination for
treatment of different causes of infertility. Presented at the Annual Meeting of the Israeli Society for Fertility
Research, Weitzman Institute, Israel, 1986, p. 34.
37. Blumenfeld Z, Drugan A, Nahhas F, Bar-Ami S, Segal E, Brandes JM: Identical twins, spontaneous absortion
of multiple fetuses and IVF. Presented at the Vth International Congress on In-Vitro Fertilization and Embryo
Transfer, April 1987, Norfolk, Virginia.
38. Blumenfeld Z, Frisch L, Makler A, Brandes JM: Induction of spermatogenesis and fertility in
hypogonadotropic azoospermic men by intravenous pulsatile GnRH. Presented at the 37th annual meeting of
the Society for Gynecologic Investigation, Atlanta, Georgia, March 1987, Abstr. # 124, p. 85.
39. Blumenfeld Z, Brandes JM: Luteal dysfunction in ovulation induction - the role of repetitive human chorionic
gonadotropin supplementation during the luteal phase. Presented at the annual meeting of the Israeli Society
of Obstetrics and Gynecology, Tel Aviv, December 1987, p. 25.
40. Blumenfeld Z, Frisch L, Shen-Or S, Peleg I, Brandes JM: Corticotropin-releasing factor (CRF) stimulation
test in chronic anovulatory women (PCO). Presented at the annual meeting of the Israeli Society of Obstetrics
and Gynecology, Tel-Aviv, December 1987, p. 29.
41. Blumenfeld Z, Conn PM, Frisch L, Brandes JM: Development of antibodies against GnRH in patients treated
with pulsatile GnRH. Presented at the International Symposium on GnRH Analogues in Cancer and Human
Reproduction, Geneva, Switzerland, February 18-21, 1988.
42. Blumenfeld Z, Dirnfeld M, Beck D, Abramovici H, Brandes JM: Comparison of treatment of uterine
leiomyomata with 3 GnRH agonists analogs - efficacy and side effects. Presented at the International
Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, Switzerland, February 18-21,
1988.
43. Blumenfeld Z, Makler A, Frisch L, Brandes JM: Induction of spermatogenesis and fertility in
hypogonadotropic azoospermic men by intravenous pulsatile GnRH. Proceedings of the 1st Congress of the
International Society of Gynecologic Endocrinology, Crans Montana, Switzerland, March 1-7, 1988.
Parthenon Press, New-Jersey, USA. Edited by Genazzani AR, Petraglia F, Volpe A, Facchinetti F, 1988, pp.
5-10.
44. Blumenfeld Z, Nahhas F: Luteal dysfunction in ovulation induction - the role of repetitive human chorionic
gonadotropin supplementation during the luteal phase. Proceedings of the 1st Congress of the International
Society of Gynecologic Endocrinology, Crans Montana, Switzerland, March 1-7, 1988. Parthenon Press,
New-Jersey, USA. Edited by Genazzani AR, Petraglia F, Volpe A, Facchinetti F, 1988, pp. 329-33.
45. Blumenfeld Z, Lunenfeld B: The potentiating effect of growth hormone on follicle stimulation with human
menopausal gonadotropin. Presented at the annual meeting of the Israel Endocrine Society, Jerusalem, January
16-17, 1989.
35
.
46. Blumenfeld Z, Lunenfeld B, Brandes JM: The permissive role of growth hormone in ovulation induction with
human menopausal gonadotropin. Presented at the VIth International Congress of IVF and Assisted
Reproduction, Jerusalem, April 2-7, 1989.
47. Lunenfeld B, Menashe Y, Pariente C, Blumenfeld Z: Effect of growth hormone on ovarian responsiveness.
Presented at the International Symposium - The Functional Morphology of the Human Ovary, Glasgow,
September 17-20, 1989.
48. Blumenfeld Z, Har-El H, Peleg I, Ish-Shalom S, Ben Arieh J, Brandes JM, Karnieli E: Hyperandrogenism,
insulin resistance and acanthosis nigricans (HAIR-AN) syndrome and benign adrenal tumor simulating
virilizing adrenal carcinoma. Presented at the annual meeting of the Israeli Endocrine Society, Jerusalem,
November 8-9, 1989.
49. Nahhas F, Barnea E, Blumenfeld Z: Early pregnancy factor determination in pregnant and IVF/ET patients,
and in human embryo cultures. Presented at the 45th annual meeting of the American Fertility Society, San
Francisco, CA, November 11-16, 1989. Abstr. [035]0-128, p. S53-54.
50. Bronshtein M, Rottem S, Yoffe N, Blumenfeld Z: First and early second trimester diagnosis of nuchal cystic
hygroma by transvaginal sonography: Diverse prognosis of the septated from the non-septated lesion.
Presented at the Israeli Ob/Gyn Society yearly meeting, Medax, November 6-9, Jerusalem, Israel.
51. Blumenfeld Z: The synergistic effect of growth hormone to gonadotropins in achievement of conceptions in
"Clonidine negative" patients with unexplained infertility. Invited Lecture - The Second Congress of the
International Society of Gynecological Endocrinology, Jerusalem, Israel, March 19-23, 1990. Presented at the
VIIth World Congress of Human Reproduction, Helsinki, Finland, June 26 - July 1, 1990.
52. Blumenfeld Z, Nahhas F, Deutsch M, Peretz BA: Autoimmune etiology to premature ovarian failure incidence, induction of ovulation and pregnancies. Presented at the Second Congress of the International
Society of Gynecological Endocrinology, Jerusalem, Israel, March 19-23, 1990. Presented at the VIIth World
Congress on Human Reproduction, Helsinki, Finland, June 26-July 1, 1990.
53. Blumenfeld Z, Yoffe N, Bronshtein M: Transvaginal sonography in infertility and assisted reproduction.
Presented as invited lecture at the IInd International Symposium on IVF and Transvaginal Ultrasonography,
Dubrovnik, Yugoslavia, October 1-4, 1990.
54. Blumenfeld Z: Ovulation induction for IVF and assisted reproduction. Presented as invited lecture at the IInd
International Symposium on IVF and Transvaginal Ultrasonography, Dubrovnik, Yugoslavia, October 1-4,
1990.
55. Blumenfeld Z, Thaler I, Beck D, Brandes JM: Treatment of uterine leiomyomata with GnRH analog
(Nafarelin): A clinical protocol of interrupted (on and off) treatment. Presented as invited lecture at the IInd
International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneve, Switzerland,
November 7-11, 1990.
56. Blumenfeld Z, Baruch Y, Brandes JM: Gonadotropin-releasing hormone analogues for dysfunctional uterine
bleeding in women after liver transplantation - a new application. Presented as invited lecture at the IInd
International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneve, Switzerland,
November 7-11, 1990.
57. Blumenfeld Z: The role of GH in infertility. Presented as invited lecture at the International Conference on
Advances in Ob/Gyn, Taipei, Taiwan, December 2-6, 1990.
58. Blumenfeld Z, Beck D, Makler A, Stoler J, Brandes JM: Repetitive hCG administration in early gestation
decreases pregnancy wastage rate in gestations achieved after ovulation induction. Presented at the annual
meeting of the Israeli Fertility Association, Tel Aviv, May 1991.
59. Amit T, Dirnfeld M, Youdim MBH, Abramovici H, Brandes JM, Blumenfeld Z: Growth Hormone - Binding
Protein (GH-BP) levels in follicular fluid
from human preovulatory follicles: Correlation with serum
GH-BP levels. Presented at the 7th World Congress on IVF and Assisted Procreations, Paris, June 30-July 3,
1991.
60. Blumenfeld Z, Brandes JM, Youdim MBH, Amit T: A possible "Carry over" effect of growth hormone in
restoration of fertility in "clonidine negative" patients. Presented at the 7th World Congress on IVF and
Assisted Procreations, Paris, June 30-July 3, 1991.
36
.
61. Blumenfeld Z, Barkey RJ, Youdim MBH, Brandes JM, Amit T: Growth hormone - binding protein (GH-BP)
correlation with estrogen, progesterone, and gonadotropins in human: The effect of ovulation induction with
growth hormone, hMG, and gestation. Presented at the 7th World Congress on IVF and Assisted Procreations,
Paris, June 30-July 3, 1991.
62. Makler A, Reiss J, Stoler J, Blumenfeld Z: Direct observation and evaluation of the in-vitro effect of cigarette
smoke on sperm motility using a specially designed mini-chamber. Presented at the 7th World Congress on
IVF and Assisted Procreations, Paris, June 30-July 3, 1991.
63. Blumenfeld Z, Dirnfeld M, Shen-Or Z, Youdim MBH, Barkey RJ, Brandes JM, Amit T: Growth Hormone Binding Protein (GH-BP) in human serum and follicular fluid: Correlation with estrogen, progesterone,
testosterone and gonadotropins. Presented at the annual meeting of the Society for Gynecological
Investigation, San-Antonio, Texas, March 18-21, 1992.
64. Blumenfeld Z, Ruach M: "Paradoxical cure" of 21-hydroxylase late onset adrenal hyperplasia by cyproterone
acetate. Presented at the annual meeting of the Society for Gynecological Investigation, San-Antonio, Texas,
March 18-21, 1992.
65. Bronshtein M, Weiner Z, Blumenfeld Z: Early second trimester diagnosis of fetal gallbladder anomalies by
transvaginal sonography (TVS): Report of eleven cases. Presented at the annual meeting of the Society for
Gynecological Investigation, San-Antonio, Texas, March 18-21, 1992.
66. Weiner Z, Lorber M, Blumenfeld Z: Doppler studies of umbilical and uterine artery in patients with SLE
treated with aspirin and corticosteroids throughout pregnancy. Presented at the International Conference on
Rheumatic Diseases in Pregnancy, Jerusalem, May 17-22, 1992.
67. Lorber M, Blumenfeld Z, Scharf Y: Low molecular weight heparin (Clexan) in pregnancy in antiphospholipid
antibody syndrome. Presented at the International Conference on Rheumatic Diseases in Pregnancy,
Jerusalem, May 17-22, 1992.
68. Makler A, Makler-Shiran E, Stoler J, Blumenfeld Z, Lissak A, Abramovici H: Evaluation of motile human
spermatozoa incubated in artificial media under aerobic and anaerobic conditions. Archiv Androl ESHRE, The
Hague, July 1992.
69. Makler A, Makler-Shiran E, Stoler J, Blumenfeld Z, Lissak A, Abramovici H: Evaluation of motile human
spermatozoa incubated in artificial media under aerobic and anaerobic conditions. ARTA Twin Conferences,
Sapin-Germany, 1992.
70. Blumenfeld Z: Early pregnancy / embryonic wastage: The role of repetitive hCG supplementation during the
first eight weeks of gestation. Presented at ARTA Twin Conference, Tossa-de-Mar, Costa Brava, Spain,
August 17-20, 1992.
71. Blumenfeld Z: Transvaginal ultrasonography to evaluate anomalies of early pregnancy. Presented at ARTA
Twin Conference, Tossa-de-Mar, Costa Brava, Spain, August 17-20, 1992.
72. Blumenfeld Z: Spontaneous fetal reduction in multiple gestations assessed by transvaginal ultrasonography.
Presented at ARTA Twin Conference, Tossa-de-Mar, Costa Brava, Spain, August 17-20, 1992.
73. Blumenfeld Z: Unexplained infertility: Growth factors - role of growth hormone. Presented at ARTA Twin
Conference, Tossa-de-Mar, Costa Brava, Spain, August 17-20, 1992.
74. Lorber M, Blumenfeld Z: Low molecular weight heparin (Clexan). A promising treatment in women with
recurrent abortions in SLE and antiphospholipid antibodies syndrome. Lupus 1992; I(suppl. 1):162. Presented
at International Meeting on SLE, London, 1992.
75. Blumenfeld Z, Shen Or Z, Karniely E, Youdim MBH, Makler A, Brandes JM, Amit T: Growth hormone binding protein (GH-BP) and IGF-I levels correlate with testosterone levels in hypogonadotropic azoospermic
men treated by intravenous pulsatile GnRH pump. Presented at the Annual Meeting of the Israel Endocrine
Society, Tel-Aviv, January 26-27, 1993.
76. Blumenfeld Z, Haim N, Bentur L, Rubin A, Aaron A, Brandes JM: New clinical indications for GnRHanalogues: Menstrual asthma, thalamic hemagioma, breast carcinoma, and lymphomas in young women.
Presented at the 3rd International Symposium on GnRH Analogues in Cancer and Human Reproduction,
Geneva, February 25-28, 1993.
37
.
77. Blumenfeld Z, Lorber M, Yoffe N, Deutsch M, Beck D, Scharf Y, Brandes JM: Systemic lupus erythematosus
- a predisposition for uterine cervical dysplasia. Presented at the Israeli Meeting of Gynecologic Oncology,
Jerusalem, March 1993.
78. Blumenfeld Z, Yoffe N, Amit A, Lang N, Brandes JM: Native GnRH for triggering follicular maturation in
PCO patients undergoing hMG ovulation induction. Presented at the Annual Meeting of the Israeli Fertility
Society, Tel Aviv, April 21-22, 1993.
79. Blumenfeld Z: The role of GH in ovulation induction. Presented (invited lecture) at the 3rd International
Pituitary Congress, Los Angeles, California, June 13-15, 1993.
80. Blumenfeld Z: Polycystic ovaries syndrome - from basic science to clinical practice. Invited lecture - the 8th
Annual Meeting Eago, Ljublijana, Slovenia, October 13-16, 1993.
81. Barak A, Bronshtein M, Blumenfeld I, Har-Shai Y, Ulman Y, Kohn J, Blumenfeld Z: Detection of cleft lip
and palate by early second trimester transvaginal sonography. Presented at the Annual Meeting of the Israeli
Plastic Assocation, Israel, October 14-15, 1993.
82. Blumenfeld Z, Matza I, Ruach M, Gideoni O, Shiloh R, Shen-Or Z, Polak S: "Paradoxical Cure" of 21
hydroxylase late onset congenital adrenal hyperplasia under chronic cyproterone acetate treatment: Correlation
with HLA-B14. Presented at the Annual Meeting of Israel Endocrine Society, Jerusalem, October 19-20,
1993.
83. Blumenfeld Z, Shen-Or Z, Amit T: Growth hormone - binding protein (GH-BP) and IGF-I levels correlate
with testosterone levels in hypogonadotropic azoospermic men treated by intravenous pulsatile GnRH pump.
Presented at the 41st Annual Scientific Meeting of the Society for Gynecologic Investigation, Chicago, IL.,
March 22-25, 1994.
84. Bronshtein M, Blumenfeld Z: Extensive transvaginal sonographic (TVS) examination in the early second
trimester for the detection of fetal malformation. Presented at the 41st Annual Scientific Meeting of the
Society for Gynecologic Investigation, Chicago, IL, March 22-25, 1994.
85. Blumenfeld Z: Treatment of repeat spontaneous abortions with corticosteroids and low-dose aspirin:
biophysical follow-up, therapy, and results. Presented as an invited lecture at Symposium on Repeat
Spontaneous Abortions ("La Variabile Immunologica Nelle Problematiche Reproduttive"), Rome, March 12,
1994.
86. Makler A, Yaffe N, Stoller J, Feigin FD, Blumenfeld Z: Inability of human spermatozoa to change their
orientation in response to external chemical stimuli. Presented at the 10th annual meeting of ESHRE Brussels,
Belgium, June 27-29, 1994. Human Reproduction, August 1994, Vol. 9, Suppl. 4, Abstract No. 174, p. 71.
87. Makler A, Poppa E, Stoller J, Blumenfeld Z: Use of a sealed mini-chamber to investigate the effect of
inhalational anaesthetics on the motility of human spermatozoa. Presented at the 10th annual meeting of
ESHRE Brussels, Belgium, June 27-29, 1994. Human Reproduction, August 1994, Vol. 9, Suppl. 4, Abstract
No. 232, p. 92.
88. Makler A, Stoller J, Feigin FD, Blumenfeld Z: Evaluating the accuracy of different counting chambers using
strict counts of photographed beads. Presented at the 10th annual meeting of ESHRE Brussels, Belgium, June
27-29, 1994. Human Reproduction, August 1994, Vol. 9, Suppl. 4, Abstract No. 251, p. 99.
89. Makler A, Stoller J, Brandes MJ, Feigin FD, Blumenfeld Z: Investigation in real-time of the effect of
gravitation on human spermatozoa and their tendency to swim up and to swim down. Presented at the 10th
annual meeting of ESHRE Brussels, Belgium, June 27-29, 1994. Human Reproduction, August 1994, Vol. 9,
Suppl. 4, Abstract No. 487, p. 181.
90. Blumenfeld Z: The role of growth factors, growth hormone (GH), its receptor and binding protein in ovarian
physiology and ovulation induction - new aspects to an old problem. Presented at SAR Symposium on
Assisted Reproduction, Bled, Slovenia, October 16-19, 1994.
91. Blumenfeld Z, Avivi I, Epelbaum R, Ben-Shahar M, Linn S, Haim N: Prevention of irreversible ovarian
damage in young women with lymphoma by a gonadotropin-releasing hormone (GnRH) agonist in parallel to
chemotherapy. Presented at the 42nd Annual Meeting of the Society for Gynecologic Investigation, Chicago,
IL, March 15-18, 1995.
38
.
92. Blumenfeld Z, Lorber M, Nahir M, Amit A, Brenner B, Sherf Y: Systemic lupus erythematosus - the
gynecologic connection: an overview. Presented at the 4th International Conference on Systemic Lupus
Erythematosus - SLE, Jerusalem, Israel, March 26-31, 1995.
93. Schwartz A, Eytan A, Makler A, Stoler J, Goldsmith M, Livneh P, Barzilai A, Blumenfeld Z: Follow up of
fertility parameters after ligation of left spermatic vein in cases of varicocoele and male infertility. Presented
at the Annual Meeting of the Israel Fertility Society, Tel-Aviv, April 30-May 2, 1995.
94. Blumenfeld Z, Shariki K, Makler A, Stoler J, Erlik Y, Peer E, Amit T: Induction of spermatogenesis and
fertility in hypogonadotropic azoospermic men by IV pulsatile GnRH pump combined with ART in their
spouses. Presented at the Annual Meeting of the Israel Fertility Society, Tel Aviv, April 30-May 2, 1995.
95. Blumenfeld Z, Daoud D, Shen-Or Z, Engel A, Kerner H, Karnieli E: Pitfalls in the diagnosis of virilizing
ovarian and adrenal andorgen secreting tumors by selective venous catheterization and sampling. Presented at
the Annual Meeting of the Israel Fertility Society, Tel Aviv, April 30-May 2, 1995.
96. Blumenfeld Z, Amit T, Gil-Ad I: The role of GH, GH-BP, GH-RH and GH-receptor in reproduction and
ovulation induction. Presented at the 7th meeting of the European Neuroendocrine Association, Jerusalem,
October 21-25, 1995.
97. Blumenfeld Z, Haim N, Ben-Shahar M, Epelbaum R, Linn S, Avivi I: Prevention of irreversible ovarian
damage in young women with lymphoma by a gonadotropin-releasing hormone (GnRH) agonist in parallel to
chemotherapy. Presented at the 4th International Symposium on GnRH-A in Cancer and Human
Reproduction, Geneve, February 8-11, 1996.
98. Blumenfeld Z, Shariki K, Rieter M, Livneh E, Blumenfeld I, Woodruff TK: Response of human fetal pituitary
cells to Activin and Inhibin in-vitro. Presented at the annual meeting of the Society for Gynecologic
Investigation, Philadelphia, March 20-23, 1996.
99. Blumenfeld Z, Amit T, Gil-Ad I: The role of GH, GH-NP, GH-RH and GH-receptor in reproduction and
ovulation induction. Presented at the 7th meeting of the European Neuroendocrine Association, Jerusalem,
October 21-25, 1995.
100. Blumenfeld Z, Haim N, Ben-Shahar M, Epelbaum R, Linn S, Avivi I: Prevention of irreversible ovarian
damage in young women with lymphoma by a gonadotropin-releasing hormone (GnRH) agonist in parallel to
chemotherapy. Presented at the 4th International Meeting of GnRH-A in Cancer and Human Reproduction,
Geneva, Switzerland, February 8-11, 1996.
101. Blumenfeld Z, Shariki K, Ritter M, Livneh E, Blumenfeld I, Woodruff TK: Response of human fetal pituitary
cells to Activin and Inhibin in-vitro. Presented at the Annual Meeting of the Society for Gynecologic
Investigation (SGI), Philadelphia, USA, March 20-23, 1996. Supplement to J. SGI 1996; 3:85a (Abs. No. 53).
102. Ornoy A, Yacobi S, Blumenfeld Z: Culture of early state rate embryos in sera from women with spontaneous
abortions of autoimmune and unknown etiology results in a high rate of embryonic anomalies. Presented at the
Annual Meeting of the Society for Gynecologic Investigation (SGI), Philadelphia, USA, March 20-23, 1996.
Supplement to J. SGI 1996; 3:219a (Abs. No. 321).
103. Blumenfeld Z, Shabadash V, Shen-Or Z, Arnon R, Israeli E, Makler A:
The origin of ascites in the
OHSS is mainly ovarian in human. Presented at the annual meeting of the Israel Fertility Association (IFA),
Tel Aviv, May 6-7, 1996.
104. Makler A, Stoler J, Makler-Shiran E, Blumenfeld Z: Investigating the dynamics and mechanism of isolating
motile sperm percoll for IVF and IUI. Presented at the annual meeting of the Israel Fertility Association (IFA),
Tel-Aviv, May 6-7, 1996.
105. Blumenfeld Z, Shariki K, Ritter M, Haim N: Inhibin-A concentrations in sera of young women during and
following chemotherapy for lymphoma - correlation with ovarian toxicity. Presented at the Annual Meeting of
the Society for Gynecologic Investigation, San Diego, USA, March 20-22, 1997. Supplement to J. SGI 1997;
4:122a (Abstract No. 174).
106. Blumenfeld Z, Ritter M, Manor D, Shen-Or Z, Makler A, Erlik Y, Amit T: Inhibin-B concentrations increase
whereas Growth Hormone Binding Protein (GH-BP) decrease in hypogonadotropic hypogonadal (HH) men
treated by pulsatile, intravenous GnRH-ART for fertility achievement. Presented at the Annual Meeting of the
Society for Gynecologic Investigation, San Diego, USA, March 20-22, 1997. Supplement to J. SGI 1997;
4:173a (Abstract No. 373).
39
.
107. Shoval S, Blumenfeld Z: The role of glucocorticosteroids cotreatment in conjunction with hMG/hCG
superovulation in hyperandrogenic, PCOS infertile patients. Presented at the Annual Meeting of the Society
for Gynecologic Investigation, San Diego, USA, March 20-22, 1997. Supplement to J. SGI 1997; 4:127a
(Abstract No. 193).
108. Blumenfeld Z, Shabadash V, Shen-Or Z, Arnon R, Israeli E, Makler A:
The origin of ascites in the
ovarian hyperstimulation syndrome is mainly ovarian in human. Presented at the Annual Meeting of the
Society for Gynecologic Investigation, San Diego, USA, March 20-22, 1997. Supplement to J. SGI 1997;
4:123a (Abstract No. 175).
109. Atias-Pery I, Stoler J, Makler A, Blumenfeld Z: Comparison of in-vitro fertilization to IVF in patients with at
least one patent tube. Presented at the 10th World Congress on IVF/ART, Vancouver, Canada, May 24-28,
1997.
110. Dirnfeld M, Gonen Y, Goldman S, Calderon I, Abramovici H, Blumenfeld Z: Successful deliveries of three
46 XY neonates born to a 46 XY father and ... 46 XY mother. Presented at the 10th World Congress on
IVF/ART, Vancouver, Canada, May 24-28, 1997.
111. Blumenfeld Z: The ovary as the origin for OHSS. Presented at FiVIER symposium on OHSS, Valencia,
Spain, Dec. 4-5 1998.
112. Blumenfeld Z: A rationalized treatment for OHSS. Presented at FiVIER Symposium on OHSS, Valencia,
Spain, Dec. 4-5 1998.
113. Blumenfeld Z, Avivi I, Rowe J: Preservation of ovarian function in young women undergoing chemotherapy.
The 5th International Congress on GnRH-a in Cancer and Human Reproduction. Geneva, Switzerland, Feb 47, 1999.
114. Ritter M, Livneh E, Woodruff TK, Blumenfeld Z: Response of human fetal pituitary cells to TGF- and its
superfamily peptides (Activin and Inhibin) in static and dynamic incubation. The 46th Annual Meeting of the
SGI. Atlanta GA, March 10-13, 1999.
115. Blumenfeld Z. Ritter M, Coffler M, Goldman S, Gonen Y, Stoler J, Kerner H, Linn R: High Inhibin-B levels
in hypogonadotropic azoospermia is a possible ominous prognostic marker for the success of pulsatile GnRH
or hMG/hCG treatment. The 46th Annual Meeting of the SGI. Atlanta GA, March 10-13, 1999.
116. Ritter M, Shen-Orr Z, Luboshitzky R, Blumenfeld Z. Melatonin does not inhibit basal or GnRH induced LH
secretion in human fetal pituitary cells in-vitro. The Annual Meeting of the Israel Endocrine Society, Tel
Aviv, November 2-3, 1999.
117. Blumenfeld Z, Avivi I, Ritter M, Haim N, Epelbaum R, Ben-Shahar M, Rowe J. Preservation of ovarian
function in young women undergoing chemotherapy – inhibin A and B as markers of ovarian function.The
Annual Meeting of the Israel Endocrine Society, Tel Aviv, November 2-3, 1999.
118. Blumenfeld Z. “Ovarian RescuepPotection from Chemoteraputic agents”-Invited lecture, NIH Workshop:
“The ovary: Genesis, function and failure” NICHD, Bethesda MD, March 30-31,2000.
119. Avivi I, Blumenfeld Z, Ritter M, Haim N, Epelbaum R, Ben-Shachar M, Rowe JM. Ovarian function
preservation in young women with leukemia and lymphoma. Blood 94(10) Pt. 2,S1:4281,pp.240-41
120. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Geller E, Nahir M. Preservation of fertility and ovarian
function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by
chemotherapy.International Congress on Reproductive Medicine & gynecology.Tel-Aviv,April11-14,2000.
121. Blumenfeld Z, Linn R, Homburg R: Metformin as an adjuvant co-treatment in parallel to FSH/hCG in PCOS
patients undergoing COH/ART. Israel Endocrine Society” Annual meeting, Tel-aviv Jan 23-24,2001.
122. Ritter M and Blumenfeld Z.: Inhibin-B is present in the serum of both male and female fetuses during
midtrimester. Israel Endocrine Scoiety” Annual meeting, Tel-aviv Jan 23-24,2001.
123. Blumenfeld Z:Response of human fetal pituitary cells to activin, inhibin, GnRH and hypophysiotropic and
neuro-reculatory factorsin-vitro. The 6th International symposium on GnRH Analogues in Cancer and Human
Reproduction. Geneva Feb 8-11, 2001
124. Ritter M, Blumenfeld Z.: Inhibin-B is present in the serum of both male and female fetuses during
midtrimester. The 6th International symposium on GnRH Analogues in Cancer and Human Reproduction .
Geneva, Feb 8-11, 2001
40
.
125. Blumenfeld Z: Preservation of ovarian function and minimalization of chemotherapy-associated
gonadotoxicity and pof-the role of inhibin-A and B as markers. The 6th International symposium on GnRH
Analogues in Cancer and Human Reproduction. Geneva, Feb 8-11, 2001:
126. Blumenfeld Z: Preservation of ovarian function and minimalization of chemotherapy-associated
gonadotoxicity and POF.XII International workshop on the Development and function of the reproductive
organs: Advances in Reproduction Research- from Follicle Culture to Nuclear Transfer and Embryonic Stem
Cells. Maale-Hachamisha, Israel ,Apr 30th –May 3rd, 2001.
127. Blumenfeld Z, Ritter M, Woodruff T. K: Regulation of human fetal pituitary gonadotropin secretion by
recombinant human activin, inhibin, and follistatin in-vitro. The 49th annual meeting of the society for
gynecologic investigation. March 20-23, 2002, LA California. Abst. #90.
128. Tereshenkov I.K, Blumenfeld Z, Lahav M: Inhibition of cortisol production by 5α dihydrotestosterone in
H295R human adrenal tumor cells. The 49th annual meeting of the society for gynecologic investigation.
March 20-23, 2002, LA California. Abst. #308.
129. Blumenfeld Z, Ritter M: Inhibin-B is present in the serum of both male and female fetuses during
midtrimester. The 49th annual meeting of the society for gynecologic investigation. March 20-23, 2002, LA
California. Abst. #390.
130. Blumenfeld Z, Dan E, Arbel G, Ritter M, Blumenfeld I, Avivi I, Epelbaum R, Rowe J.M: Longitudinal
inhibin-A and B levels in young women during and following chemotherapy for lymphoma, correlation with
ovarian toxicity. The 49th annual meeting of the society for gynecologic investigation. March 20-23, 2002, LA
California. Abst. # 538.
131. Blumenfeld Z: Metformin as an adjuvant co-treatment in parralel to FSH/hMG/hCG in PCOS patients
undergoing COH/ART. The 49th annual meeting of the society for gynecologic investigation. March 20-23,
2002, LA California. Abst. #791.
132. Blumenfeld Z, Shachar S, Linn R, Levy Y.Increased high sensitivity CRP in the PCOS.The annual meeting of
the Israel Endocrine Society.Dec 18-19,2002.Tel-Aviv.
133. Tereshenkov IK, Blumenfeld Z, Lahav M. Interference by 5-alpha-DHT with cortisol synthesis in H295R
human adrenal tumor cells. The annual meeting of the Israel Endocrine Society.Dec 18-19,2002.Tel-Aviv.
134. Blumenfeld Z.Hormonal Ablative treatment of Endometriosis-Are We Really Improving Our Patient’s
Health? Seventh International Symposium on GnRH-analogues in Cancer and Human Reproduction.
Amsterdam, The Netherlands, February 6-9,2003. Invited Speaker.
135. Blumenfeld Z. Repeated Pregnancy Wastage.The 23rd Ann Meeting of the American Society of Reproductive
Immunology.Yale, New - Haven, Connecticut. USA. June 18-22, 2003. Invited Speaker.
136. Sarig G, Aharon A, Lanir N, Goshen H, Drugan A, Blumenfeld Z, Brenner B. Modulation of systemic and
placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications. The 49 th
ann meeting of the Int. Soc.on Thrombosis and Haemostasis. July 12-18,2003.Birmingham,UK.
137. Boulman N,.Leiba R, Shachar S, Linn R, Levy Y, Blumenfeld Z. Increased CRP- levels in the PCOS- a marker of
cardiovascular disease. The annual meeting of the Israel Fertility Association.May 14-15,2003. Tel-Aviv..
138. Boulman N,.Leiba R, Shachar S, Linn R, Levy Y, Blumenfeld Z. C-Reactive Protein levels in the PCOS- a
possible marker of cardiovascular disease. The annual meeting of the Israel Endocrine Society.December 1011th, 2003. Tel-Aviv.
139. Blumenfeld Z. Preservation of fertility and ovarian function in female cancer survivors-Efforts using
Chemoprevention to protect the ovaries. Parenthood after Cancer- an international symposium at the MD
Anderson Cancer Center. March 4-7, 2004.Houston.TX. Invited speaker.
140. Blumenfeld Z. Hormonal [GnRH-a] and non-invasive modalities for fertility presevation in-spite of
chemotherapy. The 51st annual meeting of the Society for Gynecologic Investigation [SGI]. Organizer and
moderator of Symposium on Preservation of Ovarian Function and Fertility in Survivors of Chemotherapy.
Houston.TX. March 24-27, 2004.
141. Programm des Expert Meeting: GnRH-Agonisten und Ovarschutz: Ovarian
Protection from
chemotherapeutic Agents with GnRH-Agonists. Vienna, 16.04.2004-Invited speaker.
41
.
142. Menopause Symposium. The rationale of minimizing premature ovarian failure in young women exposed to
chemotherapy by using GnRH-a. Barcelona, Spain. May 10th, 2004 -Invited speaker.
143. Invited speaker to a summer course organized by Rei Juan Carlos University, Madrid, Spain. July 2530th, 2004. 1. – Folliculogenesis and the effect of gonadotoxic agents. 2. - Preservation of Ovarian Function
and Fertility in Survivors of Chemotherapy.
144. Lior Lowenstein, Amit Damti, Giora Pillar, Zeev Blumenfeld. Evaluation of Endothelial Function in the
Polycystic Ovarian Syndrome: - Could it be affected by Metformin? The annual meeting of the Israel
Endocrine Society. Tel-Aviv, Dec.21-22, 2004.
145. Nassachev Lana, Koch Yitzhak, Shen-Orr Zilla, Blumenfeld Zeev. Gonadotropin Secretion By Human Fetal
Pituitary Cells In Response To GnRH II. The annual meeting of the Israel Endocrine Society. Tel-Aviv,
Dec.21-22, 2004.
146. Blumenfeld Zeev, Boulman Nina, Siegler Ephraim, Shachar Shai, Linn Rann, Leiba Ronith, Levy
Yishai.High C-Reactive Protein Levels Are Associated With Oral Hormonal Menopausal Therapy But Not
With Intrauterine Levonorgestrel And Transdermal Estradiol. The annual meeting of the Israel Endocrine
Society. Tel-Aviv, Dec.21-22, 2004.
147. Sarig G., Aberbach I., Schliamser L., Blumenfeld Z., Zlotzover M. and Brenner B. ProC Global Assay in the
Evaluation of Women at Risk for VTE while using Hormonal Therapy
148. Blumenfeld Zeev, Invited speaker by the Flemish Society of Obstetrics and Gynecology (VVOG) and of
the Dept of Obstetrics and Gynecology at Leuven University Hospital, Belgium, to postgraduate study
day on "Infertility and Oncology" organized for gynecologists and oncologists on: "Role of LHRH
analogues in the prevention of infertility caused by chemotherapy" on Thursday October 28th 2004.
149. Blumenfeld Zeev , Invited speaker and Chairman of Scientific session- Asian Pacific Congress on
Controversies in Obstetrics, Gynecology and Infertility Plenary Lectures. Bangkok, Thailand, Nov. 25-29,
2004.
150. Blumenfeld Z.Invited speaker – GIF Endocrinology An emerging, growing scientific discipline and its future
prospects for medical applications.February 12-16, 2006 Dead Sea, Israel. “GnRH-a decreases chemotherapy
induced gonadotoxicity and POF in young female patients with Hodgkin Lymphoma or Autoimmune Diseasepossible mechanisms and future endeavors“.
151. Blumenfeld Z. Invited speaker: RAMBAM staff meeting conference. March 9th, 2006. ‫הירסוטיזם – קצה‬.
‫הקרחון של תסמונת השחלות הפוליציסטיות – אבחנה וטיפול‬
152. Blumenfeld Zeev, Invited speaker– “Gonadal protection by previous administration of GnRH
analogues” in: “Ovarian Failure. From conception to menopause” -European Society of Gynecology
Meeting, Hospital de la Santa Creu i Sant Pau – Barcelona, May 26- 27, 2006.
153. Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”- Serono
Symposia International Foundation Conference on: Reproduction and Malignant Disease. Barcelona,
Spain - September 15-16, 2006.
154. Blumenfeld Zeev, Invited speaker –“Gender Medicine- The role of GnRH-a in preventing premature ovarian
failure in young women but not in men exposed to gonadotoxic chemotherapy”-Second international Gender
Medicine Congress. Rome , Italy, March 8-11,2007.
155. Blumenfeld Zeev, Invited speaker –“Debate - The role of medical treatment for fertility preservation”-Annual
meeting of the Society for gynecologic Investigation. Reno, Nevada, USA, March 14-18, 2007.
156. Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”-International
Symposium on Cancer and Reproduction. Valencia, Spain, March 25-27, 2007.
157. Blumenfeld Zeev, Invited speaker –“The role of medical treatment for fertility preservation”-ESHRE
workshop on Cancer and Reproduction. Brussels, Belgium, April 13-14, 2007.
158. Invited speaker –“The role of medical/surgical treatment for a malignant transformation of endometriosis – Z.
Blumenfeld”-ESHRE- Ann Meeting, Lyon, France, July 1-4, 2007.
42
.
159. Blumenfeld Zeev, Invited speaker –“Fertility Preservation despite Chemotherapy- the Role of GnRH-a,
Cryopreservation of Embrya, Oocytes, or Ovaries”- 9th GnRH-a Symposium on Cancer &
Reproduction. Berlin, Germany, February 9-10, 2008.
160. Blumenfeld Zeev, Invited speaker-”. The 13th Congress of the European Hematology Association.–“The role
of medical treatment for fertility preservation". Copenhagen, Denmark, June 13-16, 2008.
161. Blumenfeld Zeev, Invited speaker-Symposium of A-PART –“Fertility preservation in young women exposed
to chemotherapy. The role of GnRH analogues cotreatment in addition to cryopreservation of embrya,
oocytes, or ovarian tissue". Tokyo, Japan, July 20-21, 2008.
162. Blumenfeld Zeev, Invited speaker-ESHRE Campus on Fertility preservation in severe diseases –“Fertility
preservation in young women exposed to chemotherapy. The role of GnRH analogues cotreatment".
Heidelberg, Germany, November 14-15, 2008.
163. Blumenfeld Zeev, How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of
GnRH-a in addition to Cryopreservation of Embrya, Oocytes, or Ovaries. Oncofertility SymposiumOrganizer and chairman. The 38 annual meeting of the Israeli Endocrine Society-IES, Ramath-Gan, March
30-31, 2009.
164. Blumenfeld Zeev, PAP smears Screening Policy- When Is the Time to Start? The19th Israeli Medical
Association World Fellowship International Conference, Tel Aviv, Israel, April 22 - 26, 2009.
165. Blumenfeld Zeev, How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of
GnRH-a in addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The 19th Israeli Medical
Association World Fellowship International Conference, Tel Aviv, Israel, April 22 - 26, 2009.
166. Blumenfeld Z, Mischari O, Schultz N, Boulman N, Shen-Orr Z, Balbir-Gurman A. GnRH-A decreases
cyclophosphamide associated gonadotoxicity and POF in SLE. Annual meeting of the Israel Fertility
Association- 5.2009, Tel-Aviv, May11-12, 2009.
167. Dann EJ, Bar-Shalom R, Tamir A, Ben-Shachar M, Avivi I, Zuckerman T, Haddad N, Rosenbaum H,
Fineman R, Goor O, Libster D, Blumenfeld Z, Rowe JM, Epelbaum R. For Standard and High-Risk Patients
with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based on Interim Scintigraphy, Are Effective
and Female Fertility Is Preserved. American Hematology Society ann meeting 12.2009.
168. Patel B, Zuckerman Z, Leiba R, Blumenfeld Z. The protective effect of GnRH-a against chemotherapy
associated gonadal failure in stem cell transplantation. Won the best clinical poster Prize, the 39th annual
meeting of the Israeli Endocrine Society (IES). Tel-Aviv, April 13-14, 2010.
169. Cohen H, Calderon I, Dirnfeld M, Turgeman T, Blumenfeld I, Hoffer E, Blumenfeld Z. Sphingosine kinase is
not upregulated by GnRH or its analogues. The 39th annual meeting of the Israeli Endocrine Society (IES).
Tel-Aviv, April 13-14, 2010.
170. Blumenfeld Zeev, Invited speaker-WARM [World Association Reproductive Medicine]–1." Growth factors
in folliculogenesis and IVM" and 2. “Fertility preservation in women exposed to chemotherapy. The role of
GnRH-a". Moscow, Russia, October 10-13, 2010.
171. Blumenfeld, Leiba R, Linn R. Menopausal transdermal estrogen and intrauterine levonorgestreldoes not
increase CRP levels whereas oral hormone treatment may. The annual meeting of the Israel Endocrine
Society. The 40th Annual Meeting of the Israel Endocrine Society 5-7 April 2011, Nazareth.
172. Patel B, Zuckerman Z, Leiba R, Blumenfeld Z. The protective effect of GnRH-a against chemotherapy
associated gonadal failure in stem cell transplantation. Prize poster, the annual meeting of the Society for
Gynecologic Investigation (SGI). Miami Beach, Florida, USA March 16-19, 2011.
173. Cohen H, Calderon I, Dirnfeld M, Turgeman T, Blumenfeld I, Hoffer E, Blumenfeld Z. Sphingosine kinase is
not upregulated by GnRH or its analogues. The annual meeting of the Society for Gynecologic Investigation
(SGI). Miami Beach, Florida, USA March 16-19, 2011.
174. Blumenfeld Z, Mischari O, Schultz N, Boulman N, Shen-Orr Z, Balbir-Gurman A. GnRH-A may decrease
cyclophosphamide associated gonadotoxicity and POF in SLE. The annual meeting of the Society for
Gynecologic Investigation (SGI). Miami Beach, Florida, USA March 16-19, 2011.
43
.
175. Turgeman O, Dirnfeld M, Calderon I, Hashem M, Blumenfeld Z. Sphingosine-1-Phosphate [S1P] may
minimize the gonadotoxic effect of chemotherapy on human luteinized granulosa cells. Annual meeting of the
Israel Fertility Association. Tel-Aviv, May 16-17, 2011.
176. Blumenfeld Z, Invited speaker and chairman of scientific session- GnRH agonist for fertility preservation.
Thirty Years of Advances in Reproductive Endocrinology and ART: A Celebratory Congress, Montreal,
Canada, May 27-31, 2011.
177. Blumenfeld Z, Invited speaker and chairman of scientific session. "Innovations and competence in current
medical practice". [Four invited lectures: 1.Fertility preservation; 2.PCOS-state of the art; 3.Inhibin, Activin,
AMH and TGF superfamily, 4.Familial breast and ovarian cancer. Samara, Russia, Nov 24-26, 2011.
178. Blumenfeld Z. Innovations in ART. Meuhedet meeting-Innovations. Haifa. March 14th, 2012.
179. Blumenfeld Z. PCOS, CRP, and TGF superfamily. The 41st annual meeting of the Israeli Endocrine Society
(IES). Ramath-Gan, March 27-28, 2012. Session chairman and member of organizing committee.
180. Blumenfeld Z, Invited speaker- Ovarian cryopreservation and fertility preservation congress [OPFP],
Berlin, 20-22.3.2013.
181. Blumenfeld Z, Invited speaker. "Fertility show congress". [Three invited lectures: 1.Fertility preservation;
2.PCOS-state of the art; 3.Inhibin, Activin, AMH and TGF superfamily. Moscow, Russia, April 13-14, 2013.
182. Ovarian Club meeting, Paris, November 2013, (invited speaker – "Is the primordial follicle indeed
gonadotropin independent?")
183. The 11th International symposium on GnRH Analogues in Cancer and Human Reproduction. Salzburg, Feb 912, 2014 (invited speaker-."An ounce of prevention is worth a pound of cure")
184. Annual meeting of the Society for gynecologic Investigation. Florence, Italy, March 26-29, 2014. "
GnRHa cotreatment increases pregnancy rate in addition to minimizing POF rate"
185. Zur H, Leiba R, Dann EJ, Zuckerman T, Schultz N, Balbir-Gurman A, Blumenfeld Z. Ann meeting, the Israel
Fertility Association, Tel-Aviv, May26-27, 2014. Cotreatment with GnRHa before and in parallel to
gonadotoxic chemotherapy significantly preserves fertility and increases pregnancy rate in addition cyclic
ovarian function.
186. Hod Y, Kaufman Y, Blumenfeld Z, Revel A, Ore L. Ann meeting, the Israel Endocrine society, Tel-Aviv,
April 7-8, 2014. Diagnostic process until surgical confirmation of endometriosis in northen Israeli women- the
diagnostic delay and potential causes.
187. Blumenfeld Z, invited lectures:1."Why Less is more and more is less?" ; 2. "An ounce of prevention is worth a
pound of cure"- GnRHa cotreatment increases pregnancy rate in addition to minimizing POF rate" ; 2nd
World Congress on Ovulation Induction & Ovarian Stimulation Protocols-WOOSP2014, Jaipur, India,
August 7-10,2014. (Faculty and invited speaker).
44